# Oxidative Stress and Assisted Reproduction: A Comprehensive Review of Its Pathophysiological Role and Strategies for Optimizing Embryo Culture Environment

Ashok Agarwal, Israel Maldonado Rosas, Christina Anagnostopoulou, Rossella Cannarella, Florence Boitrelle, Lina Villar Munoz, Renata Finelli, Damayanthi Durairajanayagam, Ralf Henkel, Ramadan Saleh

► To cite this version:

Ashok Agarwal, Israel Maldonado Rosas, Christina Anagnostopoulou, Rossella Cannarella, Florence Boitrelle, et al.. Oxidative Stress and Assisted Reproduction: A Comprehensive Review of Its Pathophysiological Role and Strategies for Optimizing Embryo Culture Environment. Antioxidants, 2022, 11 (3), pp.477. 10.3390/antiox11030477. hal-03604047

HAL Id: hal-03604047

https://hal.inrae.fr/hal-03604047

Submitted on 30 May 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Review

# Oxidative Stress and Assisted Reproduction: A Comprehensive Review of Its Pathophysiological Role and Strategies for Optimizing Embryo Culture Environment

Ashok Agarwal 1,* ID, Israel Maldonado Rosas 2, Christina Anagnostopoulou 3, Rossella Cannarella 4,5 ID,
Florence Boitrelle 6,7 ID, Lina Villar Munoz 2, Renata Finelli 1, Damayanthi Durairajanayagam 8 ID,
Ralf Henkel 1,9,10,11 ID and Ramadan Saleh 12,13

<figure><img src="image_3.png" /></figure>

check for
updates

**Citation:** Agarwal, A.; Maldonado Rosas, I.; Anagnostopoulou, C.; Cannarella, R.; Boitrelle, F.; Munoz, L.V.; Finelli, R.; Durairajanayagam, D.; Henkel, R.; Saleh, R. Oxidative Stress and Assisted Reproduction: A Comprehensive Review of Its Pathophysiological Role and Strategies for Optimizing Embryo Culture Environment. *Antioxidants* **2022**, *11*, 477. https://doi.org/10.3390/antiox11030477

Academic Editors: Gwonhwa Song
and Nicole McPherson

Received: 7 December 2021

Accepted: 21 February 2022

Published: 28 February 2022

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_4.png" /></figure>

**Copyright:** © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

1. American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH 44195, USA; finellirenata@gmail.com (R.F.); rhenkel@uwc.ac.za (R.H.)

2. Citmer Reproductive Medicine, IVF LAB, Mexico City 11520, Mexico; imaldonado@citmer.mx (I.M.R.); lvillar@citmer.mx (L.V.M.)

3. Unit of Reproductive Medicine—Embryo ART, Lito Maternity Hospital, 11524 Athens, Greece; anagnostc@gmail.com

4. Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; rossella.cannarella@phd.unict.it

5. Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, MA 01605, USA

6. Reproductive Biology, Fertility Preservation, Andrology, CECOS, Poissy Hospital, 78300 Poissy, France; florenceboitrelle@yahoo.fr

7. Department BREED, UVSQ, INRAE, Paris Saclay University, 78350 Jouy-en-Josas, France

8. Faculty of Medicine, Universiti Teknologi MARA (UiTM), Sungai Buloh Campus, Jalan Hospital, Sungai Buloh 47000, Selangor, Malaysia; damayanthi.d@gmail.com

9. Department of Metabolism, Digestion and Reproduction, Imperial College London, London W2 1NY, UK

10. Department of Medical Bioscience, University of the Western Cape, Bellville, Cape Town 7530, South Africa

11. LogixX Pharma, Theale RG7 4AB, UK

12. Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag 82524, Egypt; salehr2010@yahoo.com

13. Ajyal IVF Center, Ajyal Hospital, Sohag 82524, Egypt

* Correspondence: agarwaa@ccf.org

**Abstract:** Oxidative stress (OS) due to an imbalance between reactive oxygen species (ROS) and antioxidants has been established as an important factor that can negatively affect the outcomes of assisted reproductive techniques (ARTs). Excess ROS exert their pathological effects through damage to cellular lipids, organelles, and DNA, alteration of enzymatic function, and apoptosis. ROS can be produced intracellularly, from immature sperm, oocytes, and embryos. Additionally, several external factors may induce high ROS production in the ART setup, including atmospheric oxygen, CO₂ incubators, consumables, visible light, temperature, humidity, volatile organic compounds, and culture media additives. Pathological amounts of ROS can also be generated during the cryopreservation-thawing process of gametes or embryos. Generally, these factors can act at any stage during ART, from gamete preparation to embryo development, till the blastocyst stage. In this review, we discuss the in vitro conditions and environmental factors responsible for the induction of OS in an ART setting. In addition, we describe the effects of OS on gametes and embryos. Furthermore, we highlight strategies to ameliorate the impact of OS during the whole human embryo culture period, from gametes to blastocyst stage.

**Keywords:** antioxidants; culture media; embryo development; oxidative stress; IVF; in vitro fertilization
# 1. Introduction

Assisted reproductive techniques (ARTs) represent an important treatment option for infertile couples and its utilization has constantly increased with growth rates between 2.4% and 18.3% per annum in Europe, USA, Australia, and New Zealand in the years from 2012 to 2016 [1], resulting in about 1.3 million ART cycles in 2016 in these areas. Such an increase may be caused by several factors, including socio-economic [2] and environmental factors [3]. This is also paralleled with the observation of the temporal decline of human fertility in many countries [4]. Despite great advances in the field, the success rate of ART procedures remains unsatisfactory in many cases [5] and requires further improvements.

Oxidative stress (OS) has been established as an important factor that can negatively affect ART outcomes [6–9]. Oxidative stress is defined as an imbalance between the reactive oxygen species (ROS) and the total amount of antioxidants (AOXs) in favor of the oxidants [10]. At low concentrations, ROS act physiologically as signaling molecules in several processes [11,12]. In male reproduction, these redox mechanisms play an important role in the regulation of numerous functions, including spermatogenesis, chromatin condensation, sperm maturation during transport in the epididymis, sperm hyperactivation, capacitation, acrosome reaction, and sperm-oocyte interactions [13–15]. In female reproduction, redox homeostasis is reported to be critical for folliculogenesis, implantation, and placentation [15].

On the other hand, abnormally high levels of ROS can damage cellular lipids, organelles, and DNA, alter enzymatic function, and trigger apoptosis [11,16]. ROS-induced lipid peroxidation leads to the production of highly reactive and mutagenic products, such as malondialdehyde (MDA), an important indirect molecular marker of OS [17,18]. Sperm are particularly susceptible to OS due to the high content of omega-3 polyunsaturated fatty acids (PUFA) in sperm cell membranes [19], and limited AOX defenses in their cytoplasm [20]. Lipid peroxidation of sperm causes mitochondrial membrane damage and dysfunction, and reduced adenosine triphosphate (ATP) production [21]. Additionally, lipid peroxidation reduces the fluidity of the sperm membrane, thus interfering with capacitation, acrosome reaction, and sperm-oocyte fusion [20,21]. Furthermore, pathological levels of ROS can cause sperm DNA fragmentation (SDF), either directly or indirectly via MDA [17,18]. Three recent meta-analyses revealed a correlation between elevated SDF and reduced pregnancy rates following intrauterine insemination (IUI) [22] and in vitro fertilization (IVF) [23–25], although no significant association was reported following intra-cytoplasmic sperm injection (ICSI) [23–25]. Moreover, increased SDF has been correlated with low embryo quality [23], high miscarriage rates [23,26], and low live birth rates [27] after IVF and ICSI. In females, high levels of ROS have been observed in several pathological conditions, such as polycystic ovary syndrome, endometriosis, spontaneous abortions, preeclampsia, and intrauterine growth retardation [28].

In an ART setting, several factors can be responsible for increased ROS generation, leading to suboptimal ART outcomes [29] (Figure 1). ROS can be produced intracellularly, from immature sperm, oocytes, and embryos. The latter may be particularly vulnerable to OS due to a lack of the protective antioxidants in their physiological microenvironment during in vitro ART conditions [30]. In addition, several external factors may induce OS in an ART setup, including atmospheric oxygen (pO₂, 20–21%) [31–35]. Most body tissues, including the fallopian tubes [36], function properly at oxygen concentrations of 4% to 10% [37,38]. The toxic effect of atmospheric oxygen levels on embryos has already been shown by Pabon et al. (1989) [39] and Umaoka et al. (1992) [40]. This effect is mediated by excessive production of ROS causing OS [41]. On the other hand, a really low oxygen tension (<2%) is also detrimental to embryonic development due to: (i) inhibition of essential developmental steps [42] and (ii) release of excess mitochondrial ROS [43]. The laboratory air, the gases used, ART consumables, and the quality of culture media can also contribute to OS in an ART setting [44–47]. In addition, visible light, temperature, and humidity can directly or indirectly trigger OS [46,48]. Furthermore, ROS can be generated during the cryopreservation-thawing process of gametes or embryos, thus increasing the
risk of ROS-induced cryo-damage [49,50]. All these factors can act at any stage during ART, from gamete preparation and fertilization to embryo development until the blastocyst stage. Hence, strategies to reduce the risk of OS in ART should include optimization of the laboratory environment, sperm preparation techniques, embryo culture media, and cryopreservation protocols [29].

<figure><img src="image_5.png" /><figcaption>**Figure 1.** Factors responsible for increased ROS generation in an ART setting. Reactive oxygen species (ROS) can be produced intracellularly from immature sperm, oocytes, or embryos. External sources or triggers of ROS production include inappropriately high or ultra-low oxygen tension, contamination of laboratory air, CO₂ incubators, or ART consumables (e.g., plastics, bisphenols) with volatile organic compounds (VOCs). In addition, centrifugation, visible light, temperature, humidity levels in incubators, mineral oil, additives of culture media, the in vitro fertilization (IVF)-embryo transfer (ET) technique, and cryopreservation of gametes or embryos also contribute to ROS generation in an ART setting.</figcaption></figure>

The objectives of this review are to: (1) discuss the in vitro conditions responsible for the induction of OS in an ART setting, (2) describe the effects of OS on gametes and embryos, and (3) highlight strategies to minimize the impact of OS during the entire human embryo culture period, from gametes to blastocyst stage.

## 2. Mechanism(s) of OS Production in ART

### 2.1. Stages of OS Generation during ART

#### 2.1.1. Handling of Gametes

In an ART setting, gametes undergo in vitro manipulation, which inevitably expose these cells to OS [51]. This is particularly true in sperm that have a limited amount of
intracellular AOXs [52]. During sperm preparation for ART, semen samples are usually washed, and the seminal plasma removed [51]. Seminal plasma physiologically provides AOX protection, as it contains a wide range of both enzymatic [e.g., superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), etc.] and non-enzymatic (e.g., vitamin C, vitamin E, glutathione, etc.) compounds with antioxidant properties [52]. In addition, during swim-up, sperm may come in close contact with leukocytes and immature germ cells (both of which represent major sources of ROS) before migrating to the surface [51]. Furthermore, the centrifugation steps of sperm preparation techniques further result in increased ROS generation [52], with longer centrifugation time being associated with higher amounts of ROS and sperm damage [53].

In addition, after oocyte retrieval, cumulus cells comprising the cumulus oocyte complex are removed. This should be performed as soon as possible under controlled temperature, as culture dishes can lose temperature quickly during oocyte preparation under the laminar flow hood [54] and during pipetting [55]. Temperature changes in buffered media can make pH conditions unstable, with detrimental consequences on oocytes [56,57]. Despite the improvement in culture medium composition, the natural environment in the female reproductive tract cannot be faithfully reproduced in vitro.

### 2.1.2. Embryo Cryopreservation

Currently, the use of frozen embryos in ART programs has considerably increased compared to the past. This is attributed to the development of the vitrification method and the adoption of the freeze-all strategy, as well as the possibility to obtain a surplus of embryos and avoid hyperstimulation syndrome [58]. Before the development of vitrification, slow-freezing was the most widely used method for gamete and embryo cryopreservation. However, slow-freezing has been shown to increase the formation of intra- and extracellular ice crystals, thus inducing cellular damage, apoptosis [59,60], and increased OS. Accordingly, several conditions potentially leading to OS arise during cryopreservation. These include dilution of sperm samples (and seminal fluid), exposure to toxic cryoprotectants, and pH and osmotic changes induced by cooling to cryogenic temperatures and rewarming for thawing. In line with this, a significantly increased ROS production has been reported in human gametes, as well as in mice and human embryos, during cryopreservation [61–64]. In contrast, the formation of ice crystals is lower when vitrification is performed, with lower osmotic shock due to ultra-rapid cooling [65]. Accordingly, vitrification has been associated with higher oocytes and embryos survival, and improved metabolism and blastocyst formation rate compared to slow-freezing [66,67]. Furthermore, a meta-analysis of 6590 cycles reported that embryo vitrification has no detrimental impact on ART outcomes in terms of implantation, pregnancy, and live birth rates [65].

## 2.2. Role of Laboratory Factors in OS Generation during ART

In vitro embryo culture, as a part of ART treatment, is a complex system that intends to mimic in vivo conditions. A number of factors can affect its success, as discussed below.

### (a) Oxygen

ROS, such as hydroxyl radicals (•OH), superoxide anion ($O_2^{•-}$), or hydrogen peroxide ($H_2O_2$), are extremely reactive with very short half-life times in the nanosecond ($10^{-9}$ s) (•OH; hydroxyl radicals) to millisecond range ($10^{-3}$ s) ($O_2^{•-}$; superoxide radicals) [68]. Thus, every organism must adapt to this oxidative environment. In eukaryote cells, the mitochondria are not only consuming oxygen for the energy and ATP production, but it has been shown that in the course of the electron transfer process, about 1–5% of the consumed oxygen is converted into ROS [69]. A certain limited amount of ROS is crucial for the induction of essential physiological processes such as sperm capacitation [70] or the modulation of transcription factors such as mitogen-activated protein kinases [71]. Moreover, redox homeostasis plays a vital role in embryogenesis, embryo development, and the onset of pregnancy [42].
In the female reproductive tract, physiological amounts of ROS are important for nor-
mal follicle development, oocyte maturation, ovarian steroidogenesis, and luteolysis [72,73].
During early implantation, the embryo is challenged with almost anoxic conditions in
the uterus [36]. This change in the oxygen tension from about 2% to 5% in the ovaries
to almost anoxic is accompanied by a change in the embryonic metabolism from oxida-
tive phosphorylation with low glucose levels in the fallopian tube to glycolysis with high
glucose levels in the uterus at implantation and early post-implantation [42], favoring
preimplantation embryo development and placentation [74]. After placentation, during the
so-called post-implantation embryonic metabolism switch, the glycolysis rate decreases
again, and oxidative phosphorylation increases [75]. Then, the placental blood circulation
is established and the oxygen levels increase triggering proliferation, cell growth, and
differentiation [76]. This indicates that a finely controlled redox balance is required for
fertilization, embryo development, implantation, and further differentiation [77].

Studies with human embryonic stem cells suggested that physiological oxygen con-
centration benefits embryos by reducing cellular stress and preventing epigenetic alteration
and irreversible X chromosome inactivation [78,79]. Optimum oxygen concentration for
culturing mammalian embryos in vitro has been widely debated by the scientific com-
munity over the past few decades. Fertilization, cleavage, pregnancy, and implantation
rates were not significantly different when oxygen concentrations of 5% or 20% were used
during the culture of embryos up to day 2 or day 3 [80]. However, a Cochrane systematic
review indicated that embryo culture at low oxygen concentration of 5% has a clinical
benefit on ART outcome compared with atmospheric concentrations [81]. The practice
guidelines of the European Society of Human Reproduction and Embryology (ESHRE)
recommended culture of human embryo at low oxygen concentrations ranging from 2% to
8% [82]. More recent studies indicated that low oxygen levels (5%) during embryo culture
favor increased the number of mitochondria in blastomeres in mice [83], and blastocyst
development and pregnancy rates [84–86] in humans as compared to culture in higher
(20%) oxygen concentration. Embryos are particularly sensitive to OS induced by high
(20%) atmospheric oxygen concentration at the early stages before embryonic genome
activation [87]. ROS levels in media cultured under 5% oxygen were found to be lower
than that under atmospheric oxygen concentrations [87].

A study by Kaser et al. [88] reported that embryos cultured at ultra-low oxygen concentrations (2%) are more likely to develop into good blastocysts than the respective sibling embryos cultured under 5% oxygen. On the other hand, a recent study showed that lowering oxygen tension from 5% to 2% from day 3 onwards seems not to further improve embryo development during extended human embryo culture [89].

(b) Volatile organic compounds

Volatile organic compounds (VOCs) are mainly man-made chemicals that can va-
porize under normal atmospheric conditions and have an odor such as benzene, toluene,
formaldehyde, and ethanol [44]. Contrary to common belief, the IVF lab may be less clean
in terms of VOCs compared to outside air that is relatively VOC free [44]. Common sources
of VOCs are construction materials, wood furniture, paints, adhesives, motor vehicles
emissions, and cleaning products [90]. Additionally, they may originate from various
sources in the IVF laboratory such as microorganisms, transferred from the overlying
oil to the culture medium, tanks of medical gases used for embryo culture, plastic petri
dishes, or plastic packages of disposable supplies [91]. Several studies have documented
the detrimental effect of VOCs on human and animal cells in vitro and have linked OS
induction with the toxicity of several pollutants [92–95]. ART outcomes (pregnancy and
live birth rates) are indeed linked to air quality of the ART laboratory [90,91]. In humans,
environmental pollution has been correlated with high levels of VOCs in human semen,
which also corresponded to poorer semen quality in the young males who were inhabiting
the area [96]. However, the role of VOCs in the pathogenesis of OS in an ART setting is not
clear and warrants further research.
(c) pH

* The pH of embryo culture media

One of the most crucial culture parameters is the external pH (pHe) of the culture medium. The working pHe in bicarbonate buffered culture media is only achieved after equilibration in a 37 °C incubator under a CO₂ gas phase dissolved in the solution [97]. Denuded oocytes have no or limited ability to maintain internal pH (pHi) at 7.1 [57,98]. Therefore, the pHe needs to be calibrated at a slightly higher pHi between 7.2 and 7.3 [98–100].

Embryos at the morula and blastocyst stages are more likely to stabilize their pHi than early cleavage-stage embryos and oocytes [101]. This can be achieved by extruding the excess of protons out of the cells or buffering their cytosol by the import of bicarbonate through specific transport systems present in the cell membrane [100]. If a non-oil covered culture dish is removed from the incubator, and subjected to a non-gassed atmosphere, the pH will increase in less than one minute [97]. In the latter study, the authors indicated that if the dish containing embryos is removed from the incubator, but kept at 37 °C, the pH begins to rise immediately, and reaches a maximum pH of 7.77 (0.5 mL of medium in the well) or 7.52 (1.0 mL of medium in the well) after 5 min in room air. Other authors have compared the pH in dishes containing 5 mL of oil-free medium to those in drops of 50 µL media under oil, after exposure to ambient air outside the incubator [102]. In both cases, the pH became higher than 7.45 in two minutes. Long but small changes in temperature or CO₂ concentration during embryo incubation strongly affect the culture media pH, impacting negatively on embryo development and clinical outcomes due to increased OS [54].

* The pH in handling media

The pH of human oocytes and embryos slightly varies during development, usually accepted as between 6.98 and 7.03 in oocytes [103] and 7.12 in embryos [97]. However, it is still unclear whether a pH of 7.2 is better or worse for human embryos than a pH of 7.3 in handling media [104]. Human oocytes and cleavage embryos are more able to regulate alkalinity in the cytosol induced by high levels of pHe but are unable to buffer acidosis. This suggests that the environment of external oocyte and cleavage embryos are not more acidic than that of the cell cytoplasm [105].

The increasing production of both ROS [106] and nitric oxide (NO) [107] in cells might be determined by changes on the gradient of pH in the mitochondria [106]. Thus, pH has been considered as another OS stimulator, specifically in the cellular mitochondrial respiratory chain [108].

(d) Temperature

In ART laboratories, the temperature of CO₂ incubators has traditionally been adjusted to 37 °C to mimic in vivo conditions. However, reliance on the accuracy of temperature solely on the external display of the incubators is considered incorrect. For example, the internal temperature of bench top incubators may be 37 °C, while the display shows a higher temperature [109]. Large incubators also show internal temperature variations of around ±0.3 °C [110]. Since temperature of the incubators and heating plates is almost never a reflection of the temperature of the media, temperatures should be measured directly in the embryo culture medium during an ART-like procedure. These controls are to be done regularly with metrologically qualified thermometers. Despite several studies comparing culture at 37 °C versus 36 °C, there is currently insufficient data to suggest that incubation at a more physiological, cooler temperature improves pregnancy rates [111,112]. Embryonic cells tolerate lower temperatures better than higher temperatures, thus resulting in better pregnancy rates when the incubator environment is lower than 37 °C as opposed to >37 °C [113]. On the other hand, elevated temperatures may cause heat stress in embryos and increase ROS [114]. However, the ideal temperature for in vitro culture still remains an area of debate [54].

In order to stabilize the temperature during handling, it is important to consider how manipulations and environmental conditions can affect the heat loss of the culture me-
dia [115]. Oocyte cooling to 25 °C can temporarily disrupt the microtubules and microtubule
organizing centers and displace the chromosomes, although the development to the blasto-
cyst stage of those fertilized oocytes remains similar to non-cooled controls [116]. Similar
results were obtained by exposing both human oocytes to room temperature during vitrifi-
cation and thawing procedures, reporting clinical outcomes that were comparable to that of
non-cooled cells [117]. It appears that many of the changes induced by low temperature are
reversible in many but not all oocytes on their restoration to 37 °C for 1 h [118].

(e) Humidity

Humidification of incubators can affect the osmolarity of the embryo culture, which is considered of pivotal importance for ART success [119]. In fact, hypertonic media can heavily affect embryo development and clinical outcomes [119]. These detrimental effects are believed to occur by triggering several mechanisms, such as OS, cell shrinkage, DNA, or mitochondrial damage, cell cycle arrest, and apoptosis [120]. In line with this, a recent study compared the human ART outcomes of humid culture conditions (285–290 mOsm) with that of dry culture ones (308 mOsm), reporting a significantly higher rate of miscarriage in the former [120]. However, the last Cochrane systematic review reported no difference [121]. Culture in a dry incubator may exert negative effects on embryo development due to increased OS levels [119–122].

(f) Embryo culture media

The contribution of the culture medium to ROS production and OS of gametes during ART is not clear. A study indicated significantly higher ROS levels in different cell-free culture media compared to ROS levels in follicular fluids obtained from infertile women [123]. According to the latter study, the more complex the culture media, the higher the ROS levels that are present. In another study, the rates of good quality blastocyst formation were significantly higher when culture media with lower ROS levels were used [124].

Ammonia is produced by metabolic processes in cells and causes several deleterious damages due to its high toxicity. Ammonia is the major product from glutamine [125], and induces ROS overproduction [126] and decreases mitochondrial membrane potential (MMP) [127]. To reduce the major source of ammonia in embryo culture media, the unstable L-glutamine is replaced by alanyl-glutamine or glycyl-glutamine [128]. Apart from amino acids, other factors, such as the protein supplementation, might contribute to the ammonium accumulation in culture media that also show an ammonium buildup during storage at 2–8 °C and during incubation [129].

* Culture media renewal

IVF culture media have evolved from a stage-specific medium to a single medium to satisfy embryo needs by simulating its transportation in the oviduct. Renewal of the embryo culture medium diminishes excess ammonia [130]. The benefits of single-embryo culture over sequential medium culture include the reduction in the chances of embryonic loss, contamination, and handling errors, less embryo stress, and reduced temperature and pH changes, with no difference in embryo morphokinetics and development [130,131]. However, a study found no apparent advantage in using a single medium over that of sequential medium [132].

(g) Mineral oil

Mineral oil has been a standard component of embryo culture since the early 1960s [133], however, relatively little data exists on its potential impact on embryo development. Oil is a petroleum product that can harbor embryo toxins, including zinc and peroxides [134]. Oil is widely used during embryo culture as it prevents evaporation, and helps maintain the pH, temperature, and osmolarity of the culture medium [135].

Despite high quality control measures and rigorous testing of mineral oils, there have been reports of inadequate transport and storage conditions that result in detrimental effects on embryo development. Both oil storage time and high temperature storage can
increase mineral oil peroxidation [136], with an increase in the peroxide value (POV), regardless of the oil used. This has deleterious effects on the embryo culture medium and the embryo [136,137]. Storage at room temperature in the dark for 2 months would not increase the POV, but longer storage of 6 to 15 months would increase it by 0.12 mEq/kg and 0.21 mEq/kg, respectively [137]. The POV could even reach very high values (in the order of 3.0 mEq/kg) after sun exposure for 7 weeks or UV exposure for 120 h. At elevated temperature (50 °C) in the dark, the POV increased by 0.04 and 0.10 mEq/kg in 20 and 50 days, respectively. Ideal oil storage conditions would be in the dark between 2 and 8 °C for some manufacturers or in the dark at room temperature for others [137].

Mouse embryo development up to the blastocyst stage is dependent on the POV value, with embryo death observed at day 3 for POV values of about 0.5 mEq/kg and at day 2 for POV values of 1 mEq/kg [137]. Therefore, it is important that the transport and storage conditions, as well as storage time is known and optimized. Some authors proposed an extended mouse embryo protocol to help detect poor quality oils [138]. Others recommended washing the oil using different washing media, such as distilled water, to decrease the POV and improve the oil quality [133,139].

Mineral oil may alter the embryonic culture conditions by interfering with osmolality regulation [135]. Some mineral oils can increase the osmolality of the culture medium with negative impact on embryo development [140]. The volume of the oil has recently been shown to play a role in increasing the osmolality of the embryo culture medium [119]. For example, if a microdroplet of culture medium is covered with 1300 µL of oil, evaporation is significantly decreased with subsequent reduction of osmolality, compared to using an oil volume of 700 µL. However, the low oil volume is not the only factor involved in increasing the osmolality of the embryo culture medium. Additional factors that may contribute to the rise in osmolality include the surface area-to-volume ratio of the culture medium, oil density, and oil thickness above the medium [141]. A study by Sifer et al. [142] showed significant differences in embryo quality depending on the type of oil used. However, more recently, a comparison of paraffin oil and mineral oil showed no differences in fertilization rate or live-birth rate after normal exposure during embryo culture to either oil [143]. In a very recent study, 13 marketed oils were tested [144]. The POV was very low for all the oils tested. The POV increased for all these oils after two weeks of exposure to sunlight. Even more disturbing is the fact that 2 oils out of the 13 tested and currently marketed were described as toxic to the embryo, after performing MEA tests. Thus, the choice of oil is important for the ART laboratory, to optimize the embryo culture. Well-designed, large-scale studies are warranted to address the role of oil in ART outcomes.

### (h) Light

Light is proven to be harmful to embryo culture either directly or indirectly by causing oil peroxidation and photo-oxidation of culture medium [145,146]. The toxic effect of visible light on hamster embryos may be due to increased generation of ROS [48]. Such an observation was further confirmed in human cells [147]. In fact, specific wavelengths are reported to be absorbed by enzymes of the electron transport chain [148], resulting in increased generation of ROS. This impact is reduced by using specific filters, which are able to exclude radiation in the blue spectra [149]. It is still unclear how long a cell should be exposed to light before OS increases: a transient exposure as well as 5 min have been speculated [46,48].

### (i) IVF consumables

Polystyrene- and polypropylene-based plastics routinely used in ART laboratories include centrifuge and oocyte collection tubes, pipette and filter tips, petri dishes, cell culture plates, culture medium bottles, and cryotube vials [150], as well as handling pipettes, syringes, and catheters. These consumables remain in close contact with the gametes or embryos for various durations and thereby could potentially exert a negative effect on them. Bisphenol A (BPA) is a plasticizer commonly used in polycarbonate plastics, and an endocrine disruptor with weak estrogenic activity. It has adverse effects on both
the male and female reproductive system including epigenetic alterations during gamete
development [151–153]. An earlier study reported that under regular conditions, plastic
consumables do not leach BPA into the culture medium [154]. However, a more recent
study detected Bisphenol-S (BPS), an analog of bisphenol-A, at nanomolar concentrations in
culture media, probably originating from the medium’s plastic bottle or from the medium’s
production process [150]. Despite BPS being generally less estrogenic and antiandrogenic
compared to BPA [155], evidence from animal studies showed that low doses of BPS was
sufficient to affect oocyte quality in vitro and induce OS [150,156], while low doses of
another analog, Bisphenol AF (BPAF) disrupted oocyte maturation in vitro [157]. Addi-
tionally, plastic packages containing consumables may emit VOCs that have a detrimental
effect on embryo development and implantation [45]. Therefore, off-gassing consumables
for more than 24 h in the laminar flow hood allows substances, such as aldehydes, benzene,
and styrene to dissipate, and is a common practice in many IVF laboratories [158].

3. Gamete and Embryo Responses to OS in ART

* Embryo plasticity

The developmental plasticity of the early embryo is an impressive feature [159]. Single blastomeres from 2-cell and 4-cell mouse embryos are shown to be totipotent, being capable of producing a fully formed individual, while morula and early blastocyst cells are considered pluripotent [160]. As a result, loss of one or more blastomeres due to the freeze-thaw procedure or biopsy technique in day 3 may be compensated, and not affect embryo survival and implantation [161,162]. Additionally, features such as direct cleavage, irregular division, multinucleation, and mosaicism (considered a sign of a non-viable or non-transferable embryo) have been shown to be manageable and reversible in some cases, based on data from preimplantation genetic testing [163–165]. Progress in time-lapse technology and artificial intelligence image analysis has allowed for the study and reporting of the reorganization of fragments, exclusion of blastomeres or fragments, probably used by the embryo as a means to self-correct [166,167].

However, although preimplantation embryos can adapt to adverse environmental
conditions and grow to blastocysts and implant, cellular stress may result in permanent
and inheritable epigenetic effects [168]. Adaptation to environmental challenges may result
in the development of different phenotypes through epigenetic regulation that can persist
for more than one generation [169]. Interestingly, no significant differences were found in
implantation rates after exposure to a weak acid during the first cleavage of mouse embryos,
despite detrimental effects on fetal weight and crown-rump length [170]. Additionally,
evidence from a mouse model showed that culture in a suboptimal culture medium at
20% oxygen had a dramatic effect on gene expression related to energy production, cell
survival, and cell development [171]. Generally, extensive manipulation and out of range
in vitro conditions should be avoided when possible. These may not only impact embryo
viability but also induce stress responses, triggering gene expression alteration or epigenetic
modifications, which may affect adult health and the health of future generations [172].

* Cytoplasmic responses

Gametes are able to counteract OS mainly with enzymatic and non-enzymatic AOXs,
which lie in their cytoplasm or extracellular fluids. Their levels can impact gamete quality
and the chance of fertilization. Catalase, glutathione-S-transferase (GST), and arylesterase
enzymes have been described in cumulus cells, with higher levels reported in responders
to ART stimulation protocols. These patients showed low MDA levels and better oocyte
quality compared to poor responders, which had a lower amount of AOX enzymes in
cumulus cells [173]. Furthermore, exposure of human oocytes to growth hormone, physio-
logically secreted by granulosa cells, resulted in reduced oocyte apoptosis and OS markers
in follicular fluid, and improved oocyte mitochondrial function and overall quality [174].
Recently, treatment with growth hormone resulted in increased oocyte fertilization and
embryo formation in women with polycystic ovary syndrome [174].
Antioxidant systems in sperm include SOD, catalase, GPx, non-enzymatic factors with a low molecular weight such as glutathione, N-acetylcysteine, vitamins A, E, and C, coenzyme Q10, carnitines, myoinositol, and lycopene, and micronutrients such as selenium, zinc, and copper [175]. Mature sperm have low intracellular AOX levels due to the limited amount of cytoplasm. The deficiency of seminal AOX capacity exposes the sperm to OS-induced damage [176].

* Nuclear responses

High DNA compaction reduces the ability of nuclear responses to OS in sperm. In contrast, both oocytes and embryos are able to respond to OS through several AOX pathways. One of these include the nuclear factor-E2-related factor 2 (NRF2), a nuclear factor and a transcriptional activator of genes sharing the AOX response element in their promoters. The Kelch-like ECH-associated protein 1 (Keap1) counteracts the effect of NRF2 by contributing to its degradation by ubiquitin proteasomes [177]. In vitro exposure to isoniazid in mice oocytes led to an increase in ROS and to the activation of the OS-response pathway Keap1-NRF2 [178]. Similarly, in vitro exposure to OS resulted in an up-regulation of NRF2 expression and its downstream antioxidant genes in preimplantation bovine embryos at different times of development (8-cell, 16-cell, and blastocyst stage embryos). Furthermore, competent blastocysts were found having higher NRF2 expression and lower ROS levels, opposite to non-competent ones, which had lower NRF2 expression and higher ROS levels [179].

* Effects of out-of-range culture conditions on the gametes, embryos, and offspring

The best quality-controlled IVF laboratories avoid drastic excessive ROS insults to embryos and gametes coming from out-of-range culture conditions. This strategy may not be enough to completely scavenge excess ROS levels present in the culture medium compared to the ROS levels present in follicular fluid [123,180–182]. Excessive concentrations of ROS results in cell death, however, posed cells may exhibit an adaptive response to oxidation. The typical cell response is termed preconditioning [183]. However, ART itself has been proven to have a slight adverse effect on the offspring health. A recent cohort study performed on 764 children (382 conceived by ART and the rest 382 conceived naturally) found slightly higher blood pressure and changes in left ventricular structure and function in those conceived by ART compared to the controls [184]. Other investigators have reported an increased risk of autism spectrum disorders [185] and asthma, but not allergies [186] in children conceived from ART.

When ROS are present at levels that allow gametes and embryos to develop into a live birth, there is a concern that early epigenetic modifications will produce DNA marks that will be expressed at the later stages of life and therefore have transgenerational effects [16,187]. A recent study evaluated the potential transgenerational inherited effects of environmental contaminants on the molecular alterations of sperm nuclear basic proteins (SNBP), DNA, and semen parameters of a family case, a father and son, living in the Land of Fires [188]. The authors of this study indicated high levels of seminal copper and chromium, alterations in SNBP content, and low DNA binding affinity of SNBPs. Interestingly, unstable DNA binding capacity was more evident in the son's SNBP and was correlated with a lower seminal antioxidant activity.

The human paternal genome is globally demethylated after fertilization, while the maternal genome is demethylated at a much slower rate in human embryos. Aberrant DNA methylation patterns are reported in ART patients as well as multiple imprinted loci, hypermethylation and hypomethylation events, and mosaic methylation errors, which are caused during the global demethylation after fertilization [189,190]. The tight association between ART and imprinting disorders was demonstrated by significant differences in the genome-wide DNA methylation observed in ART patients compared to spontaneously conceived patients [190]. It appears that most of the imprinting errors are produced at the zygote stage [180,181] because extending culture to the blastocyst stage does not appear to increase the risk for imprinting errors [191]. A study using abnormal in vitro
culture conditions in mouse models indicated high expression of multiple growth-related imprinted genes, resulting in aberrant fetal growth and development and negative impact on the behavior of adult mice [192].

## 4. Strategies to Minimize OS in ART

General strategies to minimize OS rely on the reduction of ROS generation and/or enhancement of the AOX capacity. Herein, we highlight few strategies that may help control OS in an ART setting:

### (a) Keeping optimal conditions of external factors

Laboratory design is highly important so that general conditions, such as room temperature, humidity, air pressure, and light, remain at optimal ranges. The location of the laboratory should be carefully chosen based on the assessment of environmental parameters to avoid areas with increased air pollution [193]. An air filtration system with high-efficiency particulate air and active carbon filters is necessary to improve air quality [91]. The number of incubators should be enough for the number of cases treated, depending on the type and capacity of the incubators [194]. Distances between incubators and workstations should be as short as possible to reduce the total time needed for each technique and avoid accidents [83].

Exposure of oocytes and embryos to suboptimal conditions in terms of temperature, pH, and oxygen is unavoidable, as many crucial steps of the IVF procedure, such as oocyte collection and denudation, ICSI, and embryo transfer, are performed outside the incubator. The pH can increase very quickly (in one or two minutes) after removal of the culture dish from the incubator [97,102]. These culture dishes, even if returned to the gassed incubator, will take a longer time (more than 30 min for non-oil-coated culture dishes, and about 35 min for droplets of 50 µL covered by oil) to re-equilibrate the pH after exposure to a non-gassed atmosphere [97,102]. Therefore, it is essential to keep the exposure of culture dishes to non-gassed atmospheres to a strict minimum [97,102]. Additionally, because of the design of disposable plastic dishes, there is no direct contact between the dish and the warming stage, and there is always an air gap formed that reduces the efficacy of the warming stages and allows the medium in the dish to cool down fast [54]. Therefore, time limitations should be imposed, and proper training of the laboratory staff is recommended to ensure faster handling and minimization of adverse events. Implementation of detailed standard operating procedures may allow keeping a limited number of oocytes in the pipette at a time and culturing a specific number of oocytes per dish.

ROS production in vitro may be caused by transient exposure of embryos to light [48]. Strategies to minimize the negative consequences of light include working under low illumination, applying red and green filters on the microscopes, and reducing the duration of oocyte and embryo handling.

Quality control is essential to maintain all parameters in an acceptable range. Quality control devices, such as thermometers, pH meters, and VOC meters, should be calibrated and all results should be reported. According to the ESHRE guidelines, an alarm and monitoring system is necessary for all critical equipment, and this may help minimize the negative impact on embryo culture in case of unexpected events such as power failure [82].

### (b) AOX supplementation in vitro

#### i. AOX supplementation of culture media

Early embryo development is not only reliant on the relevant nutrient supply, but is also crucially dependent on proper redox regulation in the different sections of the female genital tract [195]. Hence, attempts were made to reduce possible OS during the embryo culture by adding AOXs to the culture medium. A study reported significantly improved mitochondrial activity and blastocyst development in the AOX-supplemented group of aged female mice [196]. Furthermore, supplementation of culture medium with 1 nM of melatonin resulted in optimum oocyte development and nuclear maturation, whereas higher melatonin levels (105 to 107 nM) resulted in
detrimental effects on nuclear maturation [197]. Additionally, a recent review high-
lighted the beneficial effects of AOX supplementation of culture media on the growth
improvement of different species of embryos in vitro [198]. To the contrary, no signifi-
cant effects on embryo development were observed following AOX supplementation
of the culture medium [79].

A recent prospective randomized multi-center study indicated the positive effect of supplementation of the embryo culture medium with acetyl-L-carnitine, N-acetyl-L-cysteine, and α-lipoic acid in increasing the implantation and pregnancy rates in women 35–40 years [199]. Interestingly, exposure to L-ascorbic acid (10 µM) and α-tocopherol (250 µM) has been shown to enhance the development of porcine denuded oocytes from metaphase I to metaphase II, and to protect against DNA fragmentation of cumulus cells [200].

Due to the variation of oxygen tension in different sections of the female reproductive tract [70,75], the maintenance of appropriate redox levels at the relevant embryonic developmental stages is essential. Excessive amounts of AOXs have been shown to be detrimental to numerous organs and cell types, possibly through "reductive stress" [201–204] and also by paradoxically triggering mitochondrial ROS production and cytotoxicity via a glutathione mechanism [205]. Therefore, AOXs can damage cell proliferation and embryo development if not provided at the appropriate concentrations. Yet, although this concept has been shown to play a role in other cells and organs, it still must be proven in embryos.

It has recently been shown that different culture media regularly used by ART laboratories have significantly different redox levels as measured by the MiOXSYS system [203]. Studies using mouse IVF indicated that lowering OS levels by adding AOXs to the embryo culture media are beneficial in maintaining embryo viability and development [206,207].

Before a conclusion is made regarding the potential beneficial effects of in vitro AOX supplementation of embryo culture, a few points need to be noted. First, the oxygen tension to which the early embryo is exposed in the female genital tract, under physiologic conditions, is decreasing from fallopian tube to the uterus where the environment is almost anoxic [36]. Second, the embryo's metabolism during this journey is dynamic [75]. Consequently, if the in vitro conditions in an embryo culture are not meeting the requirements in terms of the oxygen tension and the redox conditions for optimum development, the embryo development may be impaired or even arrested. Therefore, the development of new technologies that possibly address the changing conditions in the fallopian tubes, and clear understanding of the redox biology of the early embryo and its natural environment in the fallopian tube and the uterus may help improve the overall ART outcomes.

ii. AOX supplementation of cryopreservation media

In animals, nano-minerals, such as selenium and zinc, have been successfully added to the culture media of gametes or embryos, or used for cryopreservation protocols of spermatozoa, oocytes, and embryos, thereby achieving a better ART outcome [208]. The supplementation of the culture medium used for gametes or embryo with SOD, in cats, has shown its effectiveness in: (1) improving the blastocyst formation rate from low-quality oocytes [209], and (2) reducing cell apoptosis and improving survival of the cumulus and oocyte unit [210]. The addition of hypotaurine, during sperm preparation before ICSI, resulted in the reduction of SDF of frozen and thawed sperm [211]. In a recent meta-analysis, other AOXs were found to improve the motility and DNA integrity of cryopreserved gametes [212]. The latter study indicated that using AOXs in cryopreservation media could increase motility by 4.60% (95% CI 3.05–6.16), viability by 5.71% (95% CI 1.72–9.71), and DNA integrity by 10.20% (95% CI 7.42–12.98) in cryopreserved-thawed sperm.

The addition of AOXs to vitrification media has been shown to decrease the OS level
during the process and increase the embryo survival rate [213].
(c) AOX supplementation in vivo

The latest Cochrane systematic review on the use of AOXs for male subfertility collected data from 6264 patients referred to fertility clinics or undergoing ART [214]. The authors of the latter study indicated a significant improvement of live birth rate (14–26% vs. 12%) and clinical pregnancy rate (12–26% vs. 7%) compared to placebo, and no difference in miscarriage rate. However, the quality of the evidence was rated as low or very low due to the studies’ heterogeneity. Similarly, the latest Cochrane review on the use of AOXs for female subfertility showed a positive effect on live birth rate and clinical pregnancy rate [215]. Examining this study in detail, the authors found an improvement in live birth rates (OR 1.79, 95% CI 1.20 to 2.67, *p* = 0.005). However, this result was based on only 7 RCTs, for a total of 124 live births from 750 couples. The exclusion of studies with high risk of bias lead to the loss of the evidence of improvement (OR 1.38, 95% CI 0.89 to 2.16). Notably, the sample size and the number of events (live births) were further reduced (n = 540 and n = 105, respectively) and this may possibly explain the results, suggesting the need for further high-quality RCTs assessing this outcome. Finally, by including 11 RCTs, the authors reported a significant increase in clinical pregnancy rates (OR 2.97, 95% CI 1.91 to 4.63, *p* < 0.0001) compared to placebo or no treatment. However, the quality of evidence was rated as low or very low. Currently, there is no consensus on the use of AOXs in the in vitro ART procedures in humans.

(d) Hormone supplementation of culture media

Recently, preclinical data have drawn attention towards the potential benefits of the addition of hormones to embryo cultures. The addition of insulin-like growth factor 2 (usually present in follicular fluid) to the culture of aged oocyte from mice, prior to fertilization, resulted in improved oocyte competence and reduced ROS production, as well as the incidence of chromosome defects in the developing embryos [216].

**5. Conclusions**

Oxidative stress has been established as an essential factor in the pathogenesis of couples' infertility and may have negative impact on the outcomes of ARTs. In this comprehensive review, we provided the details of endogenous and exogenous sources of OS in an ART setting. These may include gametes and embryos, as well as several external factors. In addition, we discussed the potential negative effects of OS on gametes and embryos. Although gametes and embryos are partially able to counterbalance OS, this may result in permanent and inheritable epigenetic effects, cell death, and poor reproductive outcomes. We have also provided strategies to reduce the production of ROS in the ART laboratory and to manage OS during the entire human embryo culture period, from gametes to blastocyst stage. Implementation of these strategies by ART practitioners may help optimize embryo culture conditions, minimize the impact of OS on gametes and embryos, and improve the overall ART outcomes.

**Author Contributions:** Conceptualization, A.A. and I.M.R.; methodology, I.M.R. and C.A.; writing—original draft preparation, I.M.R.; R.F., C.A., F.B., L.V.M., R.C., D.D., R.H. and R.S.; writing—review and editing, A.A., I.M.R.; R.F., C.A., F.B., L.V.M., R.C., D.D., R.H. and R.S.; supervision, A.A.; project administration, A.A., R.C. and I.M.R. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Acknowledgments:** Authors are thankful to the artist Ken Kula from the Cleveland Clinic's Center for Medical Art & Photography for his help with the illustrations.

**Conflicts of Interest:** The authors declare no conflict of interest.
Abbreviations

AOXs: antioxidants; ARTs: assisted reproductive techniques; ATP: adenosine triphosphate; GPx: glutathione peroxidase; GST: glutathione-S-transferase; H₂O₂: hydrogen peroxide; HEPA: high-efficiency particulate air; HVAC: heating ventilation and air conditioning; ICSI: intracytoplasmic sperm injection; IUI: intrauterine insemination; IVF: in vitro fertilization; Keap1: Kelch-like ECH-associated protein 1; MDA: malondialdehyde; MMP: mitochondrial membrane potential; NO: nitric oxide; NRF2: nuclear factor-E2-related factor 2; O₂⁻: superoxide anion; •OH: hydroxyl radicals; OS: oxidative stress; pHe: external pH; pHi: internal pH; Ppb: parts per billion; pO₂: atmospheric oxygen; POV: peroxide value; PUFA: polyunsaturated fatty acids; ROS: reactive oxygen species; SDF: sperm DNA fragmentation; SOD: superoxide dismutase; VOCs: volatile organic compounds.

References

1. De Geyter, C.; Wyns, C.; Calhaz-Jorge, C.; de Mouzon, J.; Ferraretti, A.P.; Kupka, M.; Nyboe Andersen, A.; Nygren, K.G.; Goossens, V. 20 years of the European IVF-monitoring Consortium registry: What have we learned? A comparison with registries from two other regions. *Hum. Reprod.* **2020**, *35*, 2832–2849. [CrossRef] [PubMed]

2. Götmark, F.; Andersson, M. Human fertility in relation to education, economy, religion, contraception, and family planning programs. *BMC Public Health* **2020**, *20*, 265. [CrossRef] [PubMed]

3. Skakkebæk, N.E.; Lindahl-Jacobsen, R.; Levine, H.; Andersson, A.M.; Jørgensen, N.; Main, K.M.; Lidegaard, Ø.; Priskorn, L.; Holmboe, S.A.; Bräuner, E.V.; et al. Environmental factors in declining human fertility. *Nat. Rev. Endocrinol.* **2022**, *18*, 139–157. [CrossRef] [PubMed]

4. United Nations, D.o.E.; Social Affairs, P.D. World Population Prospects 2019: Data Booklet (ST/ESA/SER.A/424). 2019. Available online: https://population.un.org/wpp/Download/Standard/Population/ (accessed on 7 December 2021).

5. Chambers, G.M.; Dyer, S.; Zegers-Hochschild, F.; de Mouzon, J.; Ishihara, O.; Banker, M.; Mansour, R.; Kupka, M.S.; Adamson, G.D. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted reproductive technology, 2014+. *Hum. Reprod.* **2021**, *36*, 2921–2934. [CrossRef] [PubMed]

6. Agarwal, A.; Allamaneni, S.S. Role of free radicals in female reproductive diseases and assisted reproduction. *Reprod. Biomed. Online* **2004**, *9*, 338–347. [CrossRef]

7. Agarwal, A.; Saleh, R.A.; Bedaiwy, M.A. Role of reactive oxygen species in the pathophysiology of human reproduction. *Fertil. Steril.* **2003**, *79*, 829–843. [CrossRef]

8. Pasqualotto, E.B.; Agarwal, A.; Sharma, R.K.; Izzo, V.M.; Pinotti, J.A.; Joshi, N.J.; Rose, B.I. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. *Fertil. Steril.* **2004**, *81*, 973–976. [CrossRef]

9. Wiener-Megnazi, Z.; Vardi, L.; Lissak, A.; Shnizer, S.; Reznick, A.Z.; Ishai, D.; Lahav-Baratz, S.; Shiloh, H.; Koifman, M.; Dirnfeld, M. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. *Fertil. Steril.* **2004**, *82* (Suppl. 3), 1171–1176. [CrossRef]

10. Sies, H. Oxidative stress: Introductory remarks. In *Oxidative Stress*; Sies, E., Ed.; Academic Press: London, UK, 1985; pp. 1–8.

11. Sies, H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. *Redox Biol.* **2017**, *11*, 613–619. [CrossRef]

12. Sies, H. Oxidative stress: A concept in redox biology and medicine. *Redox Biol.* **2015**, *4*, 180–183. [CrossRef]

13. Aitken, R.J.; Paterson, M.; Fisher, H.; Buckingham, D.W.; van Duin, M. Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the control of human sperm function. *J. Cell Sci.* **1995**, *108* Pt 5, 2017–2025. [CrossRef] [PubMed]

14. Aitken, R.J.; Ryan, A.L.; Curry, B.J.; Baker, M.A. Multiple forms of redox activity in populations of human spermatozoa. *Mol. Hum. Reprod.* **2003**, *9*, 645–661. [CrossRef] [PubMed]

15. Silva, E.; Almeida, H.; Castro, J.P. (In) Fertility and Oxidative Stress: New Insights into Novel Redox Mechanisms Controlling Fundamental Reproductive Processes. *Oxid. Med. Cell. Longev.* **2020**, *2020*, 4674896. [CrossRef] [PubMed]

16. Lettieri, G.; D'Agostino, G.; Mele, E.; Cardito, C.; Esposito, R.; Cimmino, A.; Giarra, A.; Trifuoggi, M.; Raimondo, S.; Notari, T.; et al. Discovery of the Involvement in DNA Oxidative Damage of Human Sperm Nuclear Basic Proteins of Healthy Young Men Living in Polluted Areas. *Int. J. Mol. Sci.* **2020**, *21*, 4198. [CrossRef]

17. Esterbauer, H. Cytotoxicity and genotoxicity of lipid-oxidation products. *Am. J. Clin. Nutr.* **1993**, *57*, 779S–785S; discussion 785S–786S. [CrossRef]

18. Łuczaj, W.; Skrzydlewska, E. DNA damage caused by lipid peroxidation products. *Cell. Mol. Biol. Lett.* **2003**, *8*, 391–413.

19. Dutta, S.; Majzoub, A.; Agarwal, A. Oxidative stress and sperm function: A systematic review on evaluation and management. *Arab. J. Urol.* **2019**, *17*, 87–97. [CrossRef]

20. Aitken, R.J.; Curry, B.J. Redox regulation of human sperm function: From the physiological control of sperm capacitation to the etiology of infertility and DNA damage in the germ line. *Antioxid. Redox Signal.* **2011**, *14*, 367–381. [CrossRef]
21. Moazamian, R.; Polhemus, A.; Connaughton, H.; Fraser, B.; Whiting, S.; Gharagozloo, P.; Aitken, R.J. Oxidative stress and human spermatozoa: Diagnostic and functional significance of aldehydes generated as a result of lipid peroxidation. *Mol. Hum. Reprod.* **2015**, *21*, 502–515. [CrossRef]

22. Chen, Q.; Zhao, J.Y.; Xue, X.; Zhu, G.X. The association between sperm DNA fragmentation and reproductive outcomes following intrauterine insemination, a meta analysis. *Reprod. Toxicol.* **2019**, *86*, 50–55. [CrossRef]

23. Deng, C.; Li, T.; Xie, Y.; Guo, Y.; Yang, Q.Y.; Liang, X.; Deng, C.H.; Liu, G.H. Sperm DNA fragmentation index influences assisted reproductive technology outcome: A systematic review and meta-analysis combined with a retrospective cohort study. *Andrologia* **2019**, *51*, e13263. [CrossRef] [PubMed]

24. Zhao, J.; Zhang, Q.; Wang, Y.; Li, Y. Whether sperm deoxyribonucleic acid fragmentation has an effect on pregnancy and miscarriage after in vitro fertilization/intracytoplasmic sperm injection: A systematic review and meta-analysis. *Fertil. Steril.* **2014**, *102*, 998–1005.e8. [CrossRef] [PubMed]

25. Zini, A. Are sperm chromatin and DNA defects relevant in the clinic? *Syst. Biol. Reprod. Med.* **2011**, *57*, 78–85. [CrossRef] [PubMed]

26. Robinson, L.; Gallos, I.D.; Conner, S.J.; Rajkhowa, M.; Miller, D.; Lewis, S.; Kirkman-Brown, J.; Coomarasamy, A. The effect of sperm DNA fragmentation on miscarriage rates: A systematic review and meta-analysis. *Hum. Reprod.* **2012**, *27*, 2908–2917. [CrossRef]

27. Osman, A.; Alsomait, H.; Seshadri, S.; El-Toukhy, T.; Khalaf, Y. The effect of sperm DNA fragmentation on live birth rate after IVF or ICSI: A systematic review and meta-analysis. *Reprod. Biomed. Online* **2015**, *30*, 120–127. [CrossRef]

28. Agarwal, A.; Gupta, S.; Sekhon, L.; Shah, R. Redox considerations in female reproductive function and assisted reproduction: From molecular mechanisms to health implications. *Antioxid. Redox Signal.* **2008**, *10*, 1375–1403. [CrossRef]

29. Agarwal, A.; Said, T.M.; Bedaiwy, M.A.; Banerjee, J.; Alvarez, J.G. Oxidative stress in an assisted reproductive techniques setting. *Fertil. Steril.* **2006**, *86*, 503–512. [CrossRef]

30. Nasr-Esfahani, M.H.; Johnson, M.H. How does transferrin overcome the in vitro block to development of the mouse preimplantation embryo? *J. Reprod. Fertil.* **1992**, *96*, 41–48. [CrossRef]

31. Maas, D.H.; Storey, B.T.; Mastroianni, L., Jr. Oxygen tension in the oviduct of the rhesus monkey (Macaca mulatta). *Fertil. Steril.* **1976**, *27*, 1312–1317. [CrossRef]

32. Burr, S.; Caldwell, A.; Chong, M.; Beretta, M.; Metcalf, S.; Hancock, M.; Arno, M.; Balu, S.; Kropf, V.L.; Mistry, R.K.; et al. Oxygen gradients can determine epigenetic asymmetry and cellular differentiation via differential regulation of Tet activity in embryonic stem cells. *Nucleic Acids Res.* **2018**, *46*, 1210–1226. [CrossRef]

33. Griveau, J.F.; Grizard, G.; Boucher, D.; Le Lannou, D. Influence of oxygen tension on function of isolated spermatozoa from ejaculates of oligozoospermic patients and normozoospermic fertile donors. *Hum. Reprod.* **1998**, *13*, 3108–3113. [CrossRef] [PubMed]

34. Naillat, F.; Saadeh, H.; Nowacka-Woszuk, J.; Gahurova, L.; Santos, F.; Tomizawa, S.I.; Kelsey, G. Oxygen concentration affects de novo DNA methylation and transcription in in vitro cultured oocytes. *Clin. Epigenetics* **2021**, *13*, 132. [CrossRef] [PubMed]

35. Skiles, W.M.; Kester, A.; Pryor, J.H.; Westhusin, M.E.; Golding, M.C.; Long, C.R. Oxygen-induced alterations in the expression of chromatin modifying enzymes and the transcriptional regulation of imprinted genes. *Gene Expr. Patterns* **2018**, *28*, 1–11. [CrossRef] [PubMed]

36. Leese, H.J. Metabolic control during preimplantation mammalian development. *Hum. Reprod. Update* **1995**, *1*, 63–72. [CrossRef] [PubMed]

37. Jagannathan, L.; Cuddapah, S.; Costa, M. Oxidative stress under ambient and physiological oxygen tension in tissue culture. *Curr. Pharmacol. Rep.* **2016**, *2*, 64–72. [CrossRef] [PubMed]

38. Von Mengden, L.; Klamt, F.; Smitz, J. Redox Biology of Human Cumulus Cells: Basic Concepts, Impact on Oocyte Quality, and Potential Clinical Use. *Antioxid. Redox Signal.* **2020**, *32*, 522–535. [CrossRef]

39. Pabon, J.E., Jr.; Findley, W.E.; Gibbons, W.E. The toxic effect of short exposures to the atmospheric oxygen concentration on early mouse embryonic development. *Fertil. Steril.* **1989**, *51*, 896–900. [CrossRef]

40. Umaoka, Y.; Noda, Y.; Narimoto, K.; Mori, T. Effects of oxygen toxicity on early development of mouse embryos. *Mol. Reprod. Dev.* **1992**, *31*, 28–33. [CrossRef]

41. Halliwell, B. Cell culture, oxidative stress, and antioxidants: Avoiding pitfalls. *Biomed. J.* **2014**, *37*, 99–105. [CrossRef]

42. Ufer, C.; Wang, C.C.; Borchert, A.; Heydeck, D.; Kuhn, H. Redox control in mammalian embryo development. *Antioxid. Redox Signal.* **2010**, *13*, 833–875. [CrossRef]

43. Guzy, R.D.; Schumacker, P.T. Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. *Exp. Physiol.* **2006**, *91*, 807–819. [CrossRef] [PubMed]

44. Cohen, J.; Gilligan, A.; Esposito, W.; Schimmel, T.; Dale, B. Ambient air and its potential effects on conception in vitro. *Hum. Reprod.* **1997**, *12*, 1742–1749. [CrossRef] [PubMed]

45. Esteves, S.C.; Bento, F.C. Air quality control in the ART laboratory is a major determinant of IVF success. *Asian J. Androl.* **2016**, *18*, 596–599. [CrossRef] [PubMed]

46. Goto, Y.; Noda, Y.; Mori, T.; Nakano, M. Increased generation of reactive oxygen species in embryos cultured in vitro. *Free Radic. Biol. Med.* **1993**, *15*, 69–75. [CrossRef]
47. Guérin, P.; El Mouatassim, S.; Ménézo, Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. *Hum. Reprod. Update* **2001**, *7*, 175–189. [CrossRef] [PubMed]

48. Nakayama, T.; Noda, Y.; Goto, Y.; Mori, T. Effects of visible light and other environmental factors on the production of oxygen radicals by hamster embryos. *Theriogenology* **1994**, *41*, 499–510. [CrossRef]

49. Castro, L.S.; Hamilton, T.R.; Mendes, C.M.; Nichi, M.; Barnabe, V.H.; Visintin, J.A.; Assumpção, M.E. Sperm cryodamage occurs after rapid freezing phase: Flow cytometry approach and antioxidant enzymes activity at different stages of cryopreservation. *J. Anim. Sci. Biotechnol.* **2016**, *7*, 17. [CrossRef]

50. Len, J.S.; Koh, W.S.D.; Tan, S.X. The roles of reactive oxygen species and antioxidants in cryopreservation. *Biosci. Rep.* **2019**, *39*. [CrossRef]

51. Gualtieri, R.; Kalthur, G.; Barbato, V.; Longobardi, S.; Di Rella, F.; Adiga, S.K.; Talevi, R. Sperm Oxidative Stress during In Vitro Manipulation and Its Effects on Sperm Function and Embryo Development. *Antioxidants* **2021**, *10*, 1025. [CrossRef]

52. Aitken, R.J.; Clarkson, J.S. Significance of reactive oxygen species and antioxidants in defining the efficacy of sperm preparation techniques. *J. Androl.* **1988**, *9*, 367–376. [CrossRef]

53. Shekarriz, M.; DeWire, D.M.; Thomas, A.J., Jr.; Agarwal, A. A method of human semen centrifugation to minimize the iatrogenic sperm injuries caused by reactive oxygen species. *Eur. Urol.* **1995**, *28*, 31–35. [CrossRef] [PubMed]

54. Group, Cairo Consensus. 'There is only one thing that is truly important in an IVF laboratory: Everything' Cairo Consensus Guidelines on IVF Culture Conditions. *Reprod. Biomed. Online* **2020**, *40*, 33–60. [CrossRef] [PubMed]

55. Blomfield, S.E. Characterisation of the Physical Environment of Embryos Throughout in Vitro Culture. Ph.D. Thesis, Massey University, Palmerston North, New Zealand, 2011.

56. Bagger, P.V.; Byskov, A.G.; Christiansen, M.D. Maturation of mouse oocytes in vitro is influenced by alkalization during their isolation. *J. Reprod. Fertil.* **1987**, *80*, 251–255. [CrossRef] [PubMed]

57. Lane, M.; Baltz, J.M.; Bavister, B.D. Na+/H+ antiporter activity in hamster embryos is activated during fertilization. *Dev. Biol.* **1999**, *208*, 244–252. [CrossRef]

58. D'Angelo, A. Ovarian hyperstimulation syndrome prevention strategies: Cryopreservation of all embryos. *Semin. Reprod. Med.* **2010**, *28*, 513–518. [CrossRef]

59. De Santis, L.; Coticchio, G. Theoretical and experimental basis of slow freezing. *Reprod. Biomed. Online* **2011**, *22*, 125–132. [CrossRef]

60. Rienzi, L.; Gracia, C.; Maggiulli, R.; LaBarbera, A.R.; Kaser, D.J.; Ubaldi, F.M.; Vanderpoel, S.; Racowsky, C. Oocyte, embryo and blastocyst cryopreservation in ART: Systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. *Hum. Reprod. Update* **2017**, *23*, 139–155. [CrossRef]

61. Wiener-Megnazi, Z.; Lahav-Baratz, S.; Blais, I.; Matarasso, S.; Koifman, M.; Shnizer, S.; Ishai, D.; Peer, G.; Younes, G.; Zilberlicht, A.; et al. Oxidative markers in cryopreservation medium from frozen-thawed embryos: A possible tool for improved embryo selection in in vitro fertilization? *J. Assist. Reprod. Genet.* **2016**, *33*, 731–739. [CrossRef]

62. Lane, M.; Maybach, J.M.; Gardner, D.K. Addition of ascorbate during cryopreservation stimulates subsequent embryo development. *Hum. Reprod.* **2002**, *17*, 2686–2693. [CrossRef]

63. Kumar, A.; Sridharan, T.B. Oxidative Stress-induced Changes in Fertility Status of Cryopreserved Sperm: A Diagnosis Based on Sperm Chromatin Dispersion Assay. *Cryo. Lett.* **2020**, *41*, 297–302.

64. Nohales-Córcoles, M.; Sevillano-Almerich, G.; Di Emidio, G.; Tatone, C.; Cobo, A.C.; Dumollard, R.; De Los Santos Molina, M.J. Impact of vitrification on the mitochondrial activity and redox homeostasis of human oocyte. *Hum. Reprod.* **2016**, *31*, 1850–1858. [CrossRef] [PubMed]

65. Zeng, M.; Su, S.; Li, L. Comparison of pregnancy outcomes after vitrification at the cleavage and blastocyst stage: A meta-analysis. *J. Assist. Reprod. Genet.* **2018**, *35*, 127–134. [CrossRef] [PubMed]

66. Balaban, B.; Urman, B.; Ata, B.; Isiklar, A.; Larman, M.G.; Hamilton, R.; Gardner, D.K. A randomized controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: Vitrification is associated with higher survival, metabolism and blastocyst formation. *Hum. Reprod.* **2008**, *23*, 1976–1982. [CrossRef] [PubMed]

67. AbdelHafez, F.F.; Desai, N.; Abou-Setta, A.M.; Falcone, T.; Goldfarb, J. Slow freezing, vitrification and ultra-rapid freezing of human embryos: A systematic review and meta-analysis. *Reprod. Biomed. Online* **2010**, *20*, 209–222. [CrossRef]

68. Halliwell, B.; Gutteridge, J.M.C. *Free Radicals in Biology and Medicine*, 2nd ed.; Oxford University Press: Oxford, UK, 1998.

69. Boveris, A.; Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. *Biochem. J.* **1973**, *134*, 707–716. [CrossRef] [PubMed]

70. O'Flaherty, C. Redox regulation of mammalian sperm capacitation. *Asian J. Androl.* **2015**, *17*, 583–590. [CrossRef]

71. Filomeni, G.; Rotilio, G.; Ciriolo, M.R. Disulfide relays and phosphorylative cascades: Partners in redox-mediated signaling pathways. *Cell Death Differ.* **2005**, *12*, 1555–1563. [CrossRef]

72. Agarwal, A.; Gupta, S.; Sharma, R.K. Role of oxidative stress in female reproduction. *Reprod. Biol. Endocrinol.* **2005**, *3*, 28. [CrossRef]

73. Vega, M.; Carrasco, I.; Castillo, T.; Troncoso, J.L.; Videla, L.A.; Devoto, L. Functional luteolysis in response to hydrogen peroxide in human luteal cells. *J. Endocrinol.* **1995**, *147*, 177–182. [CrossRef]

74. Rodesch, F.; Simon, P.; Donner, C.; Jauniaux, E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. *Obstet. Gynecol.* **1992**, *80*, 283–285.
75. Hansen, J.M.; Jones, D.P.; Harris, C. The Redox Theory of Development. *Antioxid. Redox Signal.* **2020**, *32*, 715–740. [CrossRef] [PubMed]

76. Dennery, P.A. Effects of oxidative stress on embryonic development. *Birth Defects Res. C Embryo Today* **2007**, *81*, 155–162. [CrossRef] [PubMed]

77. Ng, K.Y.B.; Mingels, R.; Morgan, H.; Macklon, N.; Cheong, Y. In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: A systematic review. *Hum. Reprod. Update* **2018**, *24*, 15–34. [CrossRef]

78. Lengner, C.J.; Gimelbrant, A.A.; Erwin, J.A.; Cheng, A.W.; Guenther, M.G.; Welstead, G.G.; Alagappan, R.; Frampton, G.M.; Xu, P.; Muffat, J.; et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. *Cell* **2010**, *141*, 872–883. [CrossRef] [PubMed]

79. Xie, P.; Sun, Y.; Ouyang, Q.; Hu, L.; Tan, Y.; Zhou, X.; Xiong, B.; Zhang, Q.; Yuan, D.; Pan, Y.; et al. Physiological oxygen prevents frequent silencing of the DLK1-DIO3 cluster during human embryonic stem cells culture. *Stem. Cells* **2014**, *32*, 391–401. [CrossRef]

80. Dumoulin, J.C.; Meijers, C.J.; Bras, M.; Coonen, E.; Geraedts, J.P.; Evers, J.L. Effect of oxygen concentration on human in-vitro fertilization and embryo culture. *Hum. Reprod.* **1999**, *14*, 465–469. [CrossRef]

81. Bontekoe, S.; Mantikou, E.; van Wely, M.; Seshadri, S.; Repping, S.; Mastenbroek, S. Low oxygen concentrations for embryo culture in assisted reproductive technologies. *Cochrane Database Syst. Rev.* **2012**, *7*, CD008950. [CrossRef]

82. De los Santos, M.J.; Apter, S.; Coticchio, G.; Debrock, S.; Lundin, K.; Plancha, C.E.; Prados, F.; Rienzi, L.; Verheyen, G.; Woodward, B.; et al. Revised guidelines for good practice in IVF laboratories (2015). *Hum. Reprod.* **2016**, *31*, 685–686. [CrossRef]

83. Belli, M.; Zhang, L.; Liu, X.; Donjacour, A.; Ruggeri, E.; Palmerini, M.G.; Nottola, S.A.; Macchiarelli, G.; Rinaudo, P. Oxygen concentration alters mitochondrial structure and function in in vitro fertilized preimplantation mouse embryos. *Hum. Reprod.* **2019**, *34*, 601–611. [CrossRef]

84. Belli, M.; Antonouli, S.; Palmerini, M.G.; Bianchi, S.; Bernardi, S.; Khalili, M.A.; Donfrancesco, O.; Nottola, S.A.; Macchiarelli, G. The effect of low and ultra-low oxygen tensions on mammalian embryo culture and development in experimental and clinical IVF. *Syst. Biol. Reprod. Med.* **2020**, *66*, 229–235. [CrossRef]

85. Gelo, N.; Kirinec, G.; Baldani, D.P.; Vrčić, H.; Ježek, D.; Milošević, M.; Stanić, P. Influence of human embryo cultivation in a classic CO2 incubator with 20% oxygen versus benchtop incubator with 5% oxygen on live births: The randomized prospective trial. *Zygote* **2019**, *27*, 131–136. [CrossRef] [PubMed]

86. Van Montfoort, A.P.A.; Arts, E.; Wijnandts, L.; Sluijmer, A.; Pelinck, M.J.; Land, J.A.; Van Echten-Arends, J. Reduced oxygen concentration during human IVF culture improves embryo utilization and cumulative pregnancy rates per cycle. *Hum. Reprod. Open* **2020**, 2020, hoz036. [CrossRef] [PubMed]

87. Herbemont, C.; Labrosse, J.; Bennani-Smires, B.; Cedrin-Durnerin, I.; Peigne, M.; Sermondade, N.; Sarandi, S.; Vivot, A.; Vicaut, E.; Talib, Z.; et al. Impact of oxygen tension according to embryo stage of development: A prospective randomized study. *Sci. Rep.* **2021**, *11*, 22313. [CrossRef] [PubMed]

88. Kaser, D.J.; Bogale, B.; Sarda, V.; Farland, L.V.; Williams, P.L.; Racowsky, C. Randomized controlled trial of low (5%) versus ultralow (2%) oxygen for extended culture using bipronucleate and tripronucleate human preimplantation embryos. *Fertil. Steril.* **2018**, *109*, 1030–1037.e2. [CrossRef]

89. De Munck, N.; Janssens, R.; Segers, I.; Tournaye, H.; Van de Velde, H.; Verheyen, G. Influence of ultra-low oxygen (2%) tension on in-vitro human embryo development. *Hum. Reprod.* **2019**, *34*, 228–234. [CrossRef]

90. Sciorio, R.; Rapalini, E.; Esteves, S.C. Air quality in the clinical embryology laboratory: A mini-review. *Ther. Adv. Reprod. Health* **2021**, *15*, 2633494121990684. [CrossRef]

91. Mortimer, D.; Cohen, J.; Mortimer, S.T.; Fawzy, M.; McCulloh, D.H.; Morbeck, D.E.; Pollet-Villard, X.; Mansour, R.T.; Brison, D.R.; Doshi, A.; et al. Cairo consensus on the IVF laboratory environment and air quality: Report of an expert meeting. *Reprod. Biomed. Online* **2018**, *36*, 658–674. [CrossRef]

92. Bernardini, L.; Barbosa, E.; Charão, M.F.; Brucker, N. Formaldehyde toxicity reports from in vitro and in vivo studies: A review and updated data. *Drug. Chem. Toxicol. 2020*. [CrossRef]

93. Cheah, N.P.; Pennings, J.L.; Vermeulen, J.P.; van Schooten, F.J.; Opperhuizen, A. In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells. *Toxicol. Vitr.* **2013**, *27*, 1072–1081. [CrossRef]

94. Gangwar, R.S.; Bevan, G.H.; Palanivel, R.; Das, L.; Rajagopalan, S. Oxidative stress pathways of air pollution mediated toxicity: Recent insights. *Redox Biol.* **2020**, *34*, 101545. [CrossRef]

95. Alvarez, J.G.; Touchstone, J.C.; Blasco, L.; Storey, B.T. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. *J. Androl.* **1987**, *8*, 338–348. [CrossRef] [PubMed]

96. Longo, V.; Forleo, A.; Ferramosca, A.; Notari, T.; Pappalardo, S.; Siciliano, P.; Capone, S.; Montano, L. Blood, urine and semen Volatile Organic Compound (VOC) pattern analysis for assessing health environmental impact in highly polluted areas in Italy. *Environ. Pollut.* **2021**, *286*, 117410. [CrossRef] [PubMed]

97. Conaghan, J. PH control in the embryo culture environment. In *Culture Media, Solutions, and Systems in Human ART*; Quinn, P., Ed.; Cambridge University Press: Cambridge, UK, 2014; pp. 142–154. [CrossRef]

98. Swain, J.E. Optimizing the culture environment in the IVF laboratory: Impact of pH and buffer capacity on gamete and embryo quality. *Reprod. Biomed. Online* **2010**, *21*, 6–16. [CrossRef]
99. Hentemann, M.; Mousavi, K.; Bertheussen, K. Differential pH in embryo culture. *Fertil. Steril.* **2011**, *95*, 1291–1294. [CrossRef] [PubMed]

100. Lane, M.; Gardner, D.K. Regulation of ionic homeostasis by mammalian embryos. *Semin. Reprod. Med.* **2000**, *18*, 195–204. [CrossRef]

101. Edwards, L.J.; Williams, D.A.; Gardner, D.K. Intracellular pH of the preimplantation mouse embryo: Effects of extracellular pH and weak acids. *Mol. Reprod. Dev.* **1998**, *50*, 434–442. [CrossRef]

102. Mortimer, S.T.; Mortimer, D. *Quality and Risk Management in the IVF Laboratory*, 2nd ed.; Cambridge University Press: Cambridge, UK, 2015.

103. Phillips, K.P.; Léveillé, M.C.; Claman, P.; Baltz, J.M. Intracellular pH regulation in human preimplantation embryos. *Hum. Reprod.* **2000**, *15*, 896–904. [CrossRef]

104. Swain, J.E. Is there an optimal pH for culture media used in clinical IVF? *Hum. Reprod. Update* **2012**, *18*, 333–339. [CrossRef]

105. Dale, B.; Menezo, Y.; Cohen, J.; DiMatteo, L.; Wilding, M. Intracellular pH regulation in the human oocyte. *Hum. Reprod.* **1998**, *13*, 964–970. [CrossRef]

106. Lambert, A.J.; Brand, M.D. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. *Biochem. J.* **2004**, *382*, 511–517. [CrossRef]

107. Shu, Z.; Jung, M.; Beger, H.G.; Marzinzig, M.; Han, F.; Butzer, U.; Bruckner, U.B.; Nussler, A.K. pH-dependent changes of nitric oxide, peroxynitrite, and reactive oxygen species in hepatocellular damage. *Am. J. Physiol.* **1997**, *273*, G1118–G1126. [CrossRef] [PubMed]

108. Selivanov, V.A.; Zeak, J.A.; Roca, J.; Cascante, M.; Trucco, M.; Votyakova, T.V. The role of external and matrix pH in mitochondrial reactive oxygen species generation. *J. Biol. Chem.* **2008**, *283*, 29292–29300. [CrossRef] [PubMed]

109. Jarmuz, P.; Barrett, C.; Sakkas, D. Continual temperature and humidity measurement allows more efficient and accurate monitoring of incubator performance. *Fertil. Steril.* **2014**, *102*, E133–E134. [CrossRef]

110. Walker, M.W.; Butler, J.M.; Higdon, H.L., 3rd; Boone, W.R. Temperature variations within and between incubators-a prospective, observational study. *J. Assist. Reprod. Genet.* **2013**, *30*, 1583–1585. [CrossRef] [PubMed]

111. Baak, N.A.; Cantineau, A.E.; Farquhar, C.; Brison, D.R. Temperature of embryo culture for assisted reproduction. *Cochrane Database Syst. Rev.* **2019**, *9*, Cd012192. [CrossRef]

112. Hong, K.H.; Lee, H.; Forman, E.J.; Upham, K.M.; Scott, R.T., Jr. Examining the temperature of embryo culture in in vitro fertilization: A randomized controlled trial comparing traditional core temperature (37 °C) to a more physiologic, cooler temperature (36 °C). *Fertil. Steril.* **2014**, *102*, 767–773. [CrossRef]

113. Higdon, H.L., 3rd; Blackhurst, D.W.; Boone, W.R. Incubator management in an assisted reproductive technology laboratory. *Fertil. Steril.* **2008**, *89*, 703–710. [CrossRef]

114. Amaral, C.S.; Koch, J.; Correa Júnior, E.E.; Bertolin, K.; Mujica, L.K.S.; Fiorenza, M.F.; Rosa, S.G.; Nogueira, C.W.; Comim, F.V.; Portela, V.V.M.; et al. Heat stress on oocyte or zygote compromises embryo development, impairs interferon tau production and increases reactive oxygen species and oxidative stress in bovine embryos produced in vitro. *Mol. Reprod. Dev.* **2020**, *87*, 899–909. [CrossRef]

115. Elder, K.; Johnson, M.H. The Oldham Notebooks: An analysis of the development of IVF 1969-1978. III. Variations in procedures. *Reprod. Biomed. Soc. Online* **2015**, *1*, 19–33. [CrossRef]

116. Johnson, M.H.; Pickering, S.J.; George, M.A. The influence of cooling on the properties of the zona pellucida of the mouse oocyte. *Hum. Reprod.* **1988**, *3*, 383–387. [CrossRef]

117. Kuwayama, M.; Vajta, G.; Kato, O.; Leibo, S.P. Highly efficient vitrification method for cryopreservation of human oocytes. *Reprod. Biomed. Online* **2005**, *11*, 300–308. [CrossRef]

118. Pickering, S.J.; Johnson, M.H. The influence of cooling on the organization of the meiotic spindle of the mouse oocyte. *Hum. Reprod.* **1987**, *2*, 207–216. [CrossRef] [PubMed]

119. Mestres, E.; García-Jiménez, M.; Casals, A.; Cohen, J.; Acacio, M.; Villamar, A.; Matia-Algué, Q.; Calderón, G.; Costa-Borges, N. Factors of the human embryo culture system that may affect media evaporation and osmolality. *Hum. Reprod.* **2021**, *36*, 605–613. [CrossRef]

120. Chi, H.J.; Park, J.S.; Yoo, C.S.; Kwak, S.J.; Son, H.J.; Kim, S.G.; Sim, C.H.; Lee, K.H.; Koo, D.B. Effect of evaporation-induced osmotic changes in culture media in a dry-type incubator on clinical outcomes in in vitro fertilization-embryo transfer cycles. *Clin. Exp. Reprod. Med.* **2020**, *47*, 284–292. [CrossRef] [PubMed]

121. Armstrong, S.; Bhide, P.; Jordan, V.; Pacey, A.; Marjoribanks, J.; Farquhar, C. Time-lapse systems for embryo incubation and assessment in assisted reproduction. *Cochrane Database Syst. Rev.* **2019**, *5*, Cd011320. [CrossRef] [PubMed]

122. Fawzy, M.; AbdelRahman, M.Y.; Zidan, M.H.; Abdel Hafez, F.F.; Abdelghafar, H.; Al-Inany, H.; Bedaiwy, M.A. Humid versus dry incubator: A prospective, randomized, controlled trial. *Fertil. Steril.* **2017**, *108*, 277–283. [CrossRef]

123. Martín-Romero, F.J.; Miguel-Lasobras, E.M.; Domínguez-Arroyo, J.A.; González-Carrera, E.; Alvarez, I.S. Contribution of culture media to oxidative stress and its effect on human oocytes. *Reprod. Biomed. Online* **2008**, *17*, 652–661. [CrossRef]

124. Shih, Y.F.; Lee, T.H.; Liu, C.H.; Tsao, H.M.; Huang, C.C.; Lee, M.S. Effects of reactive oxygen species levels in prepared culture media on embryo development: A comparison of two media. *Taiwan. J. Obstet. Gynecol.* **2014**, *53*, 504–508. [CrossRef]

125. Visek, W.J. Some aspects of ammonia toxicity in animal cells. *J. Dairy Sci.* **1968**, *51*, 286–295. [CrossRef]
126. Grivennikova, V.G.; Cecchini, G.; Vinogradov, A.D. Ammonium-dependent hydrogen peroxide production by mitochondria. *FEBS Lett.* **2008**, *582*, 2719–2724. [CrossRef]

127. Korshunov, S.S.; Skulachev, V.P.; Starkov, A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. *FEBS Lett.* **1997**, *416*, 15–18. [CrossRef]

128. Roth, E.; Ollenschlager, G.; Hamilton, G.; Simmel, A.; Langer, K.; Fekl, W.; Jakesz, R. Influence of two glutamine-containing dipeptides on growth of mammalian cells. *In Vitro Cell. Dev. Biol.* **1988**, *24*, 696–698. [CrossRef] [PubMed]

129. Kleijkers, S.H.; van Montfoort, A.P.; Bekers, O.; Coonen, E.; Derhaag, J.G.; Evers, J.L.; Dumoulin, J.C. Ammonium accumulation in commercially available embryo culture media and protein supplements during storage at 2–8 °C and during incubation at 37 °C. *Hum. Reprod.* **2016**, *31*, 1192–1199. [CrossRef] [PubMed]

130. Reed, M.L.; Hamic, A.; Thompson, D.J.; Caperton, C.L. Continuous uninterrupted single medium culture without medium renewal versus sequential media culture: A sibling embryo study. *Fertil. Steril.* **2009**, *92*, 1783–1786. [CrossRef]

131. Costa-Borges, N.; Bellés, M.; Meseguer, M.; Galliano, D.; Ballesteros, A.; Calderón, G. Blastocyst development in single medium with or without renewal on day 3: A prospective cohort study on sibling donor oocytes in a time-lapse incubator. *Fertil. Steril.* **2016**, *105*, 707–713. [CrossRef]

132. Machtinger, R.; Racowsky, C. Culture systems: Single step. *Methods Mol. Biol.* **2012**, *912*, 199–209. [CrossRef]

133. Morbeck, D.E.; Leonard, P.H. Culture systems: Mineral oil overlay. *Methods Mol. Biol.* **2012**, *912*, 325–331. [CrossRef]

134. Erbach, G.T.; Bhatnagar, P.; Baltz, J.M.; Biggers, J.D. Zinc is a possible toxic contaminant of silicone oil in microdrop cultures of preimplantation mouse embryos. *Hum. Reprod.* **1995**, *10*, 3248–3254. [CrossRef]

135. Swain, J.E. Controversies in ART: Can the IVF laboratory influence preimplantation embryo aneuploidy? *Reprod. Biomed. Online* **2019**, *39*, 599–607. [CrossRef]

136. Otsuki, J.; Nagai, Y.; Chiba, K. Peroxidation of mineral oil used in droplet culture is detrimental to fertilization and embryo development. *Fertil. Steril.* **2007**, *88*, 741–743. [CrossRef]

137. Otsuki, J.; Nagai, Y.; Chiba, K. Damage of embryo development caused by peroxidized mineral oil and its association with albumin in culture. *Fertil. Steril.* **2009**, *91*, 1745–1749. [CrossRef] [PubMed]

138. Ainsworth, A.J.; Fredrickson, J.R.; Morbeck, D.E. Improved detection of mineral oil toxicity using an extended mouse embryo assay. *J. Assist. Reprod. Genet.* **2017**, *34*, 391–397. [CrossRef] [PubMed]

139. Morbeck, D.E.; Khan, Z.; Barnidge, D.R.; Walker, D.L. Washing mineral oil reduces contaminants and embryotoxicity. *Fertil. Steril.* **2010**, *94*, 2747–2752. [CrossRef] [PubMed]

140. Yumoto, K.; Iwata, K.; Sugishima, M.; Yamauchi, J.; Nakaoka, M.; Tsuneto, M.; Shimura, T.; Flaherty, S.; Mio, Y. Unstable osmolality of microdrops cultured in non-humidified incubators. *J. Assist. Reprod. Genet.* **2019**, *36*, 1571–1577. [CrossRef]

141. Mullen, S.F. Toward a predictive theoretical model for osmolality rise with non-humidified incubation: A randomized, multivariate response-surface study. *Hum. Reprod.* **2021**, *36*, 1230–1241. [CrossRef]

142. Sifer, C.; Pont, J.C.; Porcher, R.; Martin-Pont, B.; Benzacken, B.; Wolf, J.P. A prospective randomized study to compare four different mineral oils used to culture human embryos in IVF/ICSI treatments. *Eur. J. Obstet. Gynecol. Reprod. Biol.* **2009**, *147*, 52–56. [CrossRef]

143. Labied, S.; Jouan, C.; Wenders, F.; Ravet, S.; Gaspard, O.; Thonon, F.; Gridelet, V.; Henry, L.; Perrier d'Hauterive, S.; Nisolle, M. Comparison between paraffin and mineral oil covering on early human embryo culture: A prospective randomized study. *Syst. Biol. Reprod. Med.* **2019**, *65*, 81–86. [CrossRef]

144. Mestres, E.; Matia-Algué, Q.; Villamar, A.; Casals, A.; Acacio, M.; García-Jiménez, M.; Martínez-Casado, A.; Castelló, C.; Calderón, G.; Costa-Borges, N. Characterization and comparison of commercial oils used for human embryo culture. *Hum. Reprod.* **2021**, *37*, 212–225. [CrossRef]

145. Bognar, Z.; Csabai, T.J.; Pallinger, E.; Balassa, T.; Farkas, N.; Schmidt, J.; Görgey, E.; Berta, G.; Szekeres-Bartho, J.; Bodis, J. The effect of light exposure on the cleavage rate and implantation capacity of preimplantation murine embryos. *J. Reprod. Immunol.* **2019**, *132*, 21–28. [CrossRef]

146. Wale, P.L.; Gardner, D.K. The effects of chemical and physical factors on mammalian embryo culture and their importance for the practice of assisted human reproduction. *Hum. Reprod. Update* **2016**, *22*, 2–22. [CrossRef]

147. Girotti, A.W. Photosensitized oxidation of membrane lipids: Reaction pathways, cytotoxic effects, and cytoprotective mechanisms. *J. Photochem. Photobiol. B* **2001**, *63*, 103–113. [CrossRef]

148. Aggarwal, B.B.; Quintanilha, A.T.; Cammack, R.; Packer, L. Damage to mitochondrial electron transport and energy coupling by visible light. *Biochim. Biophys. Acta* **1978**, *502*, 367–382. [CrossRef]

149. Noda, Y.; Goto, Y.; Umaoka, Y.; Shiotani, M.; Nakayama, T.; Mori, T. Culture of human embryos in alpha modification of Eagle's medium under low oxygen tension and low illumination. *Fertil. Steril.* **1994**, *62*, 1022–1027. [CrossRef]

150. Togola, A.; Desmarchais, A.; Téteau, O.; Vignault, C.; Maillard, V.; Buron, C.; Bristeau, S.; Guérif, F.; Binet, A.; Elis, S. Bisphenol S is present in culture media used for ART and cell culture. *Hum. Reprod.* **2021**, *36*, 1032–1042. [CrossRef]

151. Cariati, F.; Carbone, L.; Conforti, A.; Bagnulo, F.; Peluso, S.R.; Carotenuto, C.; Buonfantino, C.; Alviggi, E.; Alviggi, C.; Strina, I. Bisphenol A-Induced Epigenetic Changes and Its Effects on the Male Reproductive System. *Front. Endocrinol.* **2020**, *11*, 453. [CrossRef]

152. Eichenlaub-Ritter, U.; Pacchierotti, F. Bisphenol A Effects on Mammalian Oogenesis and Epigenetic Integrity of Oocytes: A Case Study Exploring Risks of Endocrine Disrupting Chemicals. *Biomed. Res. Int.* **2015**, *2015*, 698795. [CrossRef]
153. Lombó, M.; Fernández-Díez, C.; González-Rojo, S.; Herráez, M.P. Genetic and epigenetic alterations induced by bisphenol A exposure during different periods of spermatogenesis: From spermatozoa to the progeny. *Sci. Rep.* **2019**, *9*, 18029. [CrossRef]

154. Gatimel, N.; Lacroix, M.Z.; Chanthavisouk, S.; Picard-Hagen, N.; Gayrard, V.; Parinaud, J.; Léandri, R.D. Bisphenol A in culture media and plastic consumables used for ART. *Hum. Reprod.* **2016**, *31*, 1436–1444. [CrossRef]

155. Rosenmai, A.K.; Dybdahl, M.; Pedersen, M.; Alice van Vugt-Lussenburg, B.M.; Wedebye, E.B.; Taxvig, C.; Vinggaard, A.M. Are structural analogues to bisphenol a safe alternatives? *Toxicol. Sci.* **2014**, *139*, 35–47. [CrossRef]

156. Nourian, A.; Soleimanzadeh, A.; Shalizar Jalali, A.; Najafi, G. Effects of bisphenol-S low concentrations on oxidative stress status and in vitro fertilization potential in mature female mice. *Vet. Res. Forum.* **2017**, *8*, 341–345.

157. Nakano, K.; Nishio, M.; Kobayashi, N.; Hiradate, Y.; Hoshino, Y.; Sato, E.; Tanemura, K. Comparison of the effects of BPA and BPAF on oocyte spindle assembly and polar body release in mice. *Zygote* **2016**, *24*, 172–180. [CrossRef] [PubMed]

158. Santos, J.T.; Soobrian, L.; Kashyap, S. Off-gassing plasticware to decrease the toxicity effect in embryo culture. *JBRA Assist. Reprod.* **2021**, *25*, 428–433. [CrossRef] [PubMed]

159. Roseboom, T.J. Developmental plasticity and its relevance to assisted human reproduction. *Hum. Reprod.* **2018**, *33*, 546–552. [CrossRef] [PubMed]

160. Maemura, M.; Taketsuru, H.; Nakajima, Y.; Shao, R.; Kakihara, A.; Nogami, J.; Ohkawa, Y.; Tsukada, Y.I. Totipotency of mouse zygotes extends to single blastomeres of embryos at the four-cell stage. *Sci. Rep.* **2021**, *11*, 11167. [CrossRef] [PubMed]

161. Magli, M.C.; Gianaroli, L.; Fortini, D.; Ferraretti, A.P.; Munné, S. Impact of blastomere biopsy and cryopreservation techniques on human embryo viability. *Hum. Reprod.* **1999**, *14*, 770–773. [CrossRef] [PubMed]

162. Wu, Y.T.; Li, C.; Zhu, Y.M.; Zou, S.H.; Wu, Q.F.; Wang, L.P.; Wu, Y.; Yin, R.; Shi, C.Y.; Lin, J.; et al. Outcomes of neonates born following transfers of frozen-thawed cleavage-stage embryos with blastomere loss: A prospective, multicenter, cohort study. *BMC Med.* **2018**, *16*, 96. [CrossRef]

163. Balakier, H.; Sojecki, A.; Motamedi, G.; Librach, C. Impact of multinucleated blastomeres on embryo developmental competence, morphokinetics, and aneuploidy. *Fertil. Steril.* **2016**, *106*, 608–614.e602. [CrossRef]

164. Lagalla, C.; Tarozzi, N.; Sciajno, R.; Wells, D.; Di Santo, M.; Nadalini, M.; Distratis, V.; Borini, A. Embryos with morphokinetic abnormalities may develop into euploid blastocysts. *Reprod. Biomed. Online* **2017**, *34*, 137–146. [CrossRef]

165. Zhan, Q.; Ye, Z.; Clarke, R.; Rosenwaks, Z.; Zaninovic, N. Direct Unequal Cleavages: Embryo Developmental Competence, Genetic Constitution and Clinical Outcome. *PLoS ONE* **2016**, *11*, e0166398. [CrossRef]

166. Coticchio, G.; Lagalla, C.; Sturmey, R.; Pennetta, F.; Borini, A. The enigmatic morula: Mechanisms of development, cell fate determination, self-correction and implications for ART. *Hum. Reprod. Update* **2019**, *25*, 422–438. [CrossRef]

167. Orvieto, R.; Shimon, C.; Rienstein, S.; Jonish-Grossman, A.; Shani, H.; Aizer, A. Do human embryos have the ability of self-correction? *Reprod. Biol. Endocrinol.* **2020**, *18*, 98. [CrossRef] [PubMed]

168. Li, W.; Goossens, K.; Van Poucke, M.; Forier, K.; Braeckmans, K.; Van Soom, A.; Peelman, L.J. High oxygen tension increases global methylation in bovine 4-cell embryos and blastocysts but does not affect general retrotransposon expression. *Reprod. Fertil. Dev.* **2016**, *28*, 948–959. [CrossRef] [PubMed]

169. Bateson, P.; Gluckman, P.; Hanson, M. The biology of developmental plasticity and the Predictive Adaptive Response hypothesis. *J. Physiol.* **2014**, *592*, 2357–2368. [CrossRef]

170. Zander-Fox, D.L.; Mitchell, M.; Thompson, J.G.; Lane, M. Alterations in mouse embryo intracellular pH by DMO during culture impair implantation and fetal growth. *Reprod. Biomed. Online* **2010**, *21*, 219–229. [CrossRef] [PubMed]

171. Feuer, S.; Liu, X.; Donjacour, A.; Simbulan, R.; Maltepe, E.; Rinaudo, P. Common and specific transcriptional signatures in mouse embryos and adult tissues induced by in vitro procedures. *Reproduction* **2016**. [CrossRef]

172. Ramos-Ibeas, P.; Heras, S.; Gómez-Redondo, I.; Planells, B.; Fernández-González, R.; Pericuesta, E.; Laguna-Barraza, R.; Pérez-Cerezales, S.; Gutiérrez-Adán, A. Embryo responses to stress induced by assisted reproductive technologies. *Mol. Reprod. Dev.* **2019**, *86*, 1292–1306. [CrossRef]

173. Tural, R.; Karakaya, C.; Erdem, M.; Aykol, Z.; Karabacak, R.O.; Kavutçu, M. Investigation of oxidative stress status in cumulus cells in patients with in vitro fertilization. *Turk. J. Med. Sci.* **2021**, *51*, 1969–1975. [CrossRef]

174. Gong, Y.; Luo, S.; Fan, P.; Jin, S.; Zhu, H.; Deng, T.; Quan, Y.; Huang, W. Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: A randomized controlled trial. *Sci. Rep.* **2020**, *10*, 18769. [CrossRef]

175. Gupta, S.; Finelli, R.; Agarwal, A.; Henkel, R. Total antioxidant capacity-Relevance, methods and clinical implications. *Andrologia* **2021**, *53*, e13624. [CrossRef]

176. Calogero, A.E.; Condorelli, R.A.; Russo, G.I.; La Vignera, S. Conservative Nonhormonal Options for the Treatment of Male Infertility: Antibiotics, Anti-Inflammatory Drugs, and Antioxidants. *Biomed. Res. Int.* **2017**, *2017*, 4650182. [CrossRef]

177. Lee, J.; Jang, J.; Park, S.M.; Yang, S.R. An Update on the Role of Nrf2 in Respiratory Disease: Molecular Mechanisms and Therapeutic Approaches. *Int. J. Mol. Sci.* **2021**, *22*, 8406. [CrossRef] [PubMed]

178. Qiao, P.; Zhang, Y.; Yang, Y.; Meng, R.; Xu, Z.; Jiang, X.; Zhang, Y.; Zhang, C.; Su, J. Oral isoniazid causes oxidative stress, oocyte deterioration and infertility in mice. *Toxicology* **2021**, *455*, 152749. [CrossRef] [PubMed]

179. Amin, A.; Gad, A.; Salilew-Wondim, D.; Prastowo, S.; Held, E.; Hoelker, M.; Rings, F.; Tholen, E.; Neuhoff, C.; Looft, C.; et al. Bovine embryo survival under oxidative-stress conditions is associated with activity of the NRF2-mediated oxidative-stress-response pathway. *Mol. Reprod. Dev.* **2014**, *81*, 497–513. [CrossRef]
180. Maldonado Rosas, I.; Agarwal, A.; Medina, I.J.; Domínguez, L.R.; Martínez, M.I.; Fernández, S.M.; Fernández, L.A.; Martínez, E.M.; Carranza, R.L.; Mendoza, C.B.; et al. The addition of antioxidants every 12 hour to the culture medium significantly increases the rate of total usable and expanded blastocysts in patients with advanced maternal age: A prospective study of 1520 sibling human oocytes. *Fertil. Steril.* **2021**, *116*, e170-e171. [CrossRef]

181. Maldonado Rosas, I.; Agarwal, A.; Medina, I.J.; Domínguez, L.R.; Martínez, M.I.; Leyva Macías, L.B.; Vazquez, F.S.; Fer-nández, S.M.; Carranza, R.L.; Villar Muñoz, L.G.; et al. The adjustment of oxi-dation reduction potential (ORP) levels in culture media to the overall levels of follicular fluid produces significantly higher embryo ploidy rates in patients: A prospective randomized study of sibling oocytes. *Fertil. Steril.* **2021**, *116*, e171. [CrossRef]

182. Maldonando Rosas, I.; Agarwal, A.; Medina, I.J.; Fernández, S.M.; Fernández, L.A.; León, E.B.; Carranza, R.L.; Orozco, E.G.; Muñoz, L.G.V.; Domínguez, L.R.; et al. The addition of anti-oxidants every 12 hour to the culture medium significantly increases the rates of total usable and expanded blastocysts in recipient patients: A prospective randomized control study of 553 sibling donor oocytes. *Fertil. Steril.* **2021**, *116*, e127-e128. [CrossRef]

183. Akki, R.; Siracusa, R.; Cordaro, M.; Remigante, A.; Morabito, R.; Errami, M.; Marino, A. Adaptation to oxidative stress at cellular and tissue level. *Arch. Physiol. Biochem.* **2019**. [CrossRef]

184. Cui, L.; Zhao, M.; Zhang, Z.; Zhou, W.; Lv, J.; Hu, J.; Ma, J.; Fang, M.; Yang, L.; Magnussen, C.G.; et al. Assessment of Cardiovascular Health of Children Ages 6 to 10 Years Conceived by Assisted Reproductive Technology. *JAMA Netw. Open* **2021**, *4*, e2132602. [CrossRef]

185. Andreadou, M.T.; Katsaras, G.N.; Talimtzi, P.; Doxani, C.; Zintzaras, E.; Stefanidis, I. Association of assisted reproductive technology with autism spectrum disorder in the offspring: An updated systematic review and meta-analysis. *Eur. J. Pediatr.* **2021**, *180*, 2741-2755. [CrossRef]

186. Wijs, L.A.; Fusco, M.R.; Doherty, D.A.; Keelan, J.A.; Hart, R.J. Asthma and allergies in offspring conceived by ART: A systematic review and meta-analysis. *Hum. Reprod. Update* **2021**, *28*, 132-148. [CrossRef]

187. Ménézo, Y.; Elder, K. Epigenetic remodeling of chromatin in human ART: Addressing deficiencies in culture media. *J. Assist. Reprod. Genet.* **2020**, *37*, 1781-1788. [CrossRef]

188. Lettieri, G.; Marra, F.; Moriello, C.; Prisco, M.; Notari, T.; Trifuoggi, M.; Giarra, A.; Bosco, L.; Montano, L.; Piscopo, M. Molecular Alterations in Spermatozoa of a Family Case Living in the Land of Fires. A First Look at Possible Transgenerational Effects of Pollutants. *Int. J. Mol. Sci.* **2020**, *21*, 6710. [CrossRef] [PubMed]

189. Bliek, J.; Verde, G.; Callaway, J.; Maas, S.M.; De Crescenzo, A.; Sparago, A.; Cerrato, F.; Russo, S.; Ferraiuolo, S.; Rinaldi, M.M.; et al. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. *Eur. J. Hum. Genet.* **2009**, *17*, 611-619. [CrossRef] [PubMed]

190. Hattori, H.; Hiura, H.; Kitamura, A.; Miyauchi, N.; Kobayashi, N.; Takahashi, S.; Okae, H.; Kyono, K.; Kagami, M.; Ogata, T.; et al. Association of four imprinting disorders and ART. *Clin. Epigenetics* **2019**, *11*, 21. [CrossRef] [PubMed]

191. White, C.R.; Denomme, M.M.; Tekpetey, F.R.; Feyles, V.; Power, S.G.; Mann, M.R. High Frequency of Imprinted Methylation Errors in Human Preimplantation Embryos. *Sci. Rep.* **2015**, *5*, 17311. [CrossRef] [PubMed]

192. Fernández-Gonzalez, R.; Moreira, P.; Bilbao, A.; Jiménez, A.; Pérez-Crespo, M.; Ramírez, M.A.; Rodríguez De Fonseca, F.; Pintado, B.; Gutiérrez-Adán, A. Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior. *Proc. Natl. Acad. Sci. USA* **2004**, *101*, 5880-5885. [CrossRef]

193. Nagy, Z.P.; Varghese, A.; Agarwal, A. *In Vitro Fertilization: A Textbook of Current and Emerging Methods and Devices, In Vitro Fertilization*; Springer Nature: Cham, Switzerland, 2019.

194. Swain, J.E. Decisions for the IVF laboratory: Comparative analysis of embryo culture incubators. *Reprod. Biomed. Online* **2014**, *28*, 535-547. [CrossRef]

195. Houghton, F.D. HYPOXIA AND REPRODUCTIVE HEALTH: Hypoxic regulation of preimplantation embryos: Lessons from human embryonic stem cells. *Reproduction* **2021**, *161*, F41-F51. [CrossRef]

196. Silva, E.; Greene, A.F.; Strauss, K.; Herrick, J.R.; Schoolcraft, W.B.; Krisher, R.L. Antioxidant supplementation during in vitro culture improves mitochondrial function and development of embryos from aged female mice. *Reprod. Fertil. Dev.* **2015**, *27*, 975-983. [CrossRef]

197. Wei, D.; Zhang, C.; Xie, J.; Song, X.; Yin, B.; Liu, Q.; Hu, L.; Hao, H.; Geng, J.; Wang, P. Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro. *J. Assist. Reprod. Genet.* **2013**, *30*, 933-938. [CrossRef]

198. Zarbakhsh, S. Effect of antioxidants on preimplantation embryo development in vitro: A review. *Zygote* **2021**, *29*, 179-193. [CrossRef] [PubMed]

199. Gardner, D.K.; Kuramoto, T.; Tanaka, M.; Mitzumoto, S.; Montag, M.; Yoshida, A. Prospective randomized multicentre comparison on sibling oocytes comparing G-Series media system with antioxidants versus standard G-Series media system. *Reprod. Biomed. Online* **2020**, *40*, 637-644. [CrossRef] [PubMed]

200. Tao, Y.; Zhou, B.; Xia, G.; Wang, F.; Wu, Z.; Fu, M. Exposure to L-ascorbic acid or alpha-tocopherol facilitates the development of porcine denuded oocytes from metaphase I to metaphase II and prevents cumulus cells from fragmentation. *Reprod. Domest. Anim.* **2004**, *39*, 52-57. [CrossRef]

201. Brewer, A.C.; Mustafi, S.B.; Murray, T.V.; Rajasekaran, N.S.; Benjamin, I.J. Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. *Antioxid. Redox Signal.* **2013**, *18*, 1114-1127. [CrossRef]
202. Fisher, D.; Mentor, S. Antioxidant-induced reductive stress has untoward consequences on the brain microvasculature. *Neural. Regen. Res.* **2017**, *12*, 743-744. [CrossRef]

203. Panner Selvam, M.K.; Agarwal, A.; Henkel, R.; Finelli, R.; Robert, K.A.; Iovine, C.; Baskaran, S. The effect of oxidative and reductive stress on semen parameters and functions of physiologically normal human spermatozoa. *Free Radic. Biol. Med.* **2020**, *152*, 375-385. [CrossRef]

204. Peris, E.; Micallef, P.; Paul, A.; Palsdottir, V.; Enejder, A.; Bauzá-Thorbrügge, M.; Olofsson, C.S.; Wernstedt Asterholm, I. Antioxidant treatment induces reductive stress associated with mitochondrial dysfunction in adipocytes. *J. Biol. Chem.* **2019**, *294*, 2340-2352. [CrossRef]

205. Zhang, H.; Limphong, P.; Pieper, J.; Liu, Q.; Rodesch, C.K.; Christians, E.; Benjamin, I.J. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. *FASEB J.* **2012**, *26*, 1442-1451. [CrossRef] [PubMed]

206. Truong, T.; Gardner, D.K. Antioxidants improve IVF outcome and subsequent embryo development in the mouse. *Hum. Reprod.* **2017**, *32*, 2404-2413. [CrossRef]

207. Truong, T.T.; Soh, Y.M.; Gardner, D.K. Antioxidants improve mouse preimplantation embryo development and viability. *Hum. Reprod.* **2016**, *31*, 1445-1454. [CrossRef]

208. Abdelnour, S.A.; Alagawany, M.; Hashem, N.M.; Farag, M.R.; Alghamdi, E.S.; Hassan, F.U.; Bilal, R.M.; Elnesr, S.S.; Dawood, M.A.O.; Nagadi, S.A.; et al. Nanominerals: Fabrication Methods, Benefits and Hazards, and Their Applications in Ruminants with Special Reference to Selenium and Zinc Nanoparticles. *Animals* **2021**, *11*, 1916. [CrossRef] [PubMed]

209. Ochota, M.; Pasieka, A.; Niżański, W. Superoxide dismutase and taurine supplementation improves in vitro blastocyst yield from poor-quality feline oocytes. *Theriogenology* **2016**, *85*, 922-927. [CrossRef] [PubMed]

210. Cocchia, N.; Corteggio, A.; Altamura, G.; Tafuri, S.; Rea, S.; Rosapane, I.; Sica, A.; Landolfi, F.; Ciani, F. The effects of superoxide dismutase addition to the transport medium on cumulus-oocyte complex apoptosis and IVF outcome in cats (Felis catus). *Reprod. Biol.* **2015**, *15*, 56-64. [CrossRef] [PubMed]

211. Brugnon, F.; Ouchchane, L.; Pons-Rejraji, H.; Artonne, C.; Farigoule, M.; Janny, L. Density gradient centrifugation prior to cryopreservation and hypotaurine supplementation improve post-thaw quality of sperm from infertile men with oligoasthenoteratozoospermia. *Hum. Reprod.* **2013**, *28*, 2045-2057. [CrossRef]

212. Ebrahimi, B.; Matavos-Aramyan, H.; Keshtgar, S. The cryoprotective effect of vitamins on human spermatozoa quality: A systematic review and meta-analysis. *Cell Tissue Bank.* **2021**. [CrossRef]

213. Truong, T.T.; Gardner, D.K. Antioxidants increase blastocyst cryosurvival and viability post-vitrification. *Hum. Reprod.* **2020**, *35*, 12-23. [CrossRef]

214. Smits, R.M.; Mackenzie-Proctor, R.; Yazdani, A.; Stankiewicz, M.T.; Jordan, V.; Showell, M.G. Antioxidants for male subfertility. *Cochrane Database Syst. Rev.* **2019**, *3*, Cd007411. [CrossRef]

215. Showell, M.G.; Mackenzie-Proctor, R.; Jordan, V.; Hart, R.J. Antioxidants for female subfertility. *Cochrane Database Syst. Rev.* **2020**, *8*, Cd007807. [CrossRef]

216. Muhammad, T.; Wan, Y.; Sha, Q.; Wang, J.; Huang, T.; Cao, Y.; Li, M.; Yu, X.; Yin, Y.; Chan, W.Y.; et al. IGF2 improves the developmental competency and meiotic structure of oocytes from aged mice. *Aging* **2020**, *13*, 2118-2134. [CrossRef]